Indoor Harvest (INQD) 10-K/A 15 Feb 19 2017 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Apr. 17, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	Indoor Harvest Corp
Entity Central Index Key	1,572,565
Document Type	10-K/A
Document Period End Date	Dec. 31, 2017
Amendment Flag	true
Amendment Description	Indoor Harvest Corp ("we", "our", the "Company") is filing this Amendment No. 1 on Form 10-K/A (the "Amendment") to restate portions of the following items of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, which we originally filed with the Securities and Exchange Commission on April 17, 2017 (the "Original Form 10-K"): (i) Item 7 of Part II "Management's Discussion and Analysis of Financial Condition and Results of Operations" (ii) Item 8 of Part II "Financial Statements" (iii) Item 15 of Part IV "Exhibits" We have also updated the signature page, the certifications of our Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2, 32.1, and 32.2 and our financial statements formatted in Extensible Business Reporting Language (XBRL). On October 17, 2018, the Board of Directors (the "Board") of the Company was notified by the Company's independent registered public accounting firm, Thayer O'Neal Company, LLC ("Thayer"), that the audited consolidated financial statements included in the Original Form 10-K should not be relied upon. Thayer informed the Board that, in July 2018, information came to its attention that led it to investigate whether the Company's acquisition of Alamo CBD LLC ("Alamo CBD") was wrongly accounted for as a business combination. Thayer concluded this investigation on October 17, 2018 and notified the Board that the Company, pursuant to generally accepted accounting principles, should have accounted for the Alamo CBD transaction as an asset acquisition. The Company noticed errors in accounting for the issuance of 7,584,008 shares of common stock for Alamo CBD and the cancellation of 2,500,000 shares of common stock by an officer of the Company. In the Original Form 10-K, the Company's management had decided to impair the goodwill created by the Alamo CBD acquisition, as there were doubts regarding when a license may be issued (the license is pending and may or may not ever be issued) and whether upon receipt of the license if it will lead to significant positive cash flows. The Company recorded an impairment of goodwill in the Statement of Operations in the audited consolidated financial statements included in the Original Form 10-K. As discussed above, management is now accounting for the acquisition of Alamo CBD as an acquisition of assets (and not a business combination) and determined it should be impaired upon acquisition. Additionally, management determined that the cancellation of shares by the Company's officer should be valued at $0 and not applied to the acquisition of assets from Alamo CBD. Therefore, there is now a $1,440,961 impairment loss of intangible assets rather than a $1,440,961 loss on impairment of goodwill. This report on Form 10-K/A has been signed as of a current date and all certifications of the Company's Chief Executive Officer and Chief Financial Officer are given as of a current date. Except as discussed above and as further described in Notes 1, 2, 6, and 9 to the audited consolidated financial statement, the Company has not modified, or updated disclosures presented in this Amendment. Accordingly, the Amendment does not reflect events occurring after the Original Form 10-K or modify or update those disclosures affected by subsequent events. Information not affected by the restatement is unchanged and reflects disclosures made at the time of the filing of the Original Form 10-K.
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 2,238,922
Entity Common Stock, Shares Outstanding		24,957,471
Trading Symbol	INQD
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 35,453	$ 78,219
Accounts receivable		34,853
Other receivable		7,323
Inventory		2,360
Prepaid rent	4,452
Unused commitment fee	50,000
Total current assets	89,905	122,755
Furniture and equipment, net	24,623	158,418
Security deposit	12,600	12,600
Intangible asset, net	5,892	7,604
Total assets	133,020	301,377
Current liabilities:
Accounts payable and accrued expenses	89,033	55,797
Convertible notes payable, net of debt discount of $27,014 and $152,617, respectively	668,912	122,383
Derivatives liability, net of discount of $213,453 and $0, respectively	341,464
Note payable, net of discount of $0 and $15,714, respectively		209,786
Accrued payroll	6,653	7,142
Deferred rent	6,239	8,513
Note payable - current portion	7,520	6,790
Billing in excess of costs and estimated earnings		20,155
Total current liabilities	1,119,821	430,566
Long term liabilities:
Note payable	12,823	20,342
Total liabilities	1,132,644	450,908
Stockholders' deficit:
Series A Convertible Preferred stock: $0.01 par value, 5,000,000 shares authorized; 750,000 and 250,000 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively	7,500	2,500
Common stock: $0.001 par value, 50,000,000 shares authorized; 25,503,678 and 15,213,512 shares issued and outstanding at December 31, 2017 and December 31, 2016, respectively	25,502	15,213
Additional paid-in capital	7,376,196	3,829,528
Accumulated deficit	(8,408,822)	(3,996,772)
Total stockholders' deficit	(999,624)	(149,531)
Total liabilities and stockholders' deficit	$ 133,020	$ 301,377

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Debt discount on convertible note payable	$ 27,014	$ 152,617
Discount on derivatives liability	213,453	0
Debt discount on note payable	$ 0	$ 15,714
Series A Convertible preferred stock, par value	$ 0.01	$ 0.01
Series A Convertible preferred stock, shares authorized	5,000,000	5,000,000
Series A Convertible preferred Stock, shares issued	750,000	250,000
Series A Convertible preferred Stock, shares outstanding	750,000	250,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	25,503,678	15,213,512
Common stock, shares outstanding	25,503,678	15,213,512

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Revenue		$ 163,996
Cost of sales		111,581
Gross profit		52,415
Operating expenses
Depreciation and amortization expense	51,507	51,484
Research and development	1,625	16,184
Loss on investment in joint venture	250,000
Impairment loss	1,440,961
Professional fees	418,092	108,093
General and administrative expenses	1,061,493	1,129,711
Total operating expenses	3,223,678	1,305,472
Loss from operations	(3,223,678)	(1,253,057)
Other income (expense)
Other income (expense)	7,196	52,323
Interest expense	(163,047)	(16,427)
Derivatives interest expense		(66,980)
Amortization of debt discount	(515,814)	(438,032)
Amortization of debt issuance costs		(20,000)
Amortization of original issuance discount		(22,500)
Loss on debt settlement		(131,944)
Loss on sale of equipment	(73,750)	(36,627)
Change in fair value of embedded derivative liability	(442,957)	(141,756)
Total other income (expense)	(1,183,372)	(821,943)
Net loss	$ (4,412,050)	$ (2,075,000)
Net loss from continuing operations per common share:
Net loss from continuing operations per share, basic and diluted	$ (0.22)	$ (0.16)
Weighted average number of common shares outstanding:
Basic and diluted	20,234,995	12,742,137

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Series A Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2015		$ 11,204	$ 2,233,663	$ (1,921,772)	$ 323,095
Balance, shares at Dec. 31, 2015		11,204,571
Issuance of common stock for cash		$ 100	49,900		50,000
Issuance of common stock for cash, shares		100,000
Issuance of common stock for services		$ 1,327	464,097		465,424
Issuance of common stock for services, shares		1,327,380
Convertible debt converted into common stock		$ 2,582	200,737		203,319
Convertible debt converted into common stock, shares		2,581,561
Beneficial conversion feature			316,269		316,269
Debt discount on warrants			30,243		30,243
Derivative liability			412,119		412,119
Issuance of preferred stock for cash	$ 2,500		122,500		125,000
Issuance of preferred stock for cash, shares	250,000
Net loss				(2,075,000)	(2,075,000)
Balance at Dec. 31, 2016	$ 2,500	$ 15,213	3,829,528	(3,996,772)	(149,531)
Balance, shares at Dec. 31, 2016	250,000	15,213,512
Issuance of common stock for cash		$ 2,060	821,940		$ 824,000
Issuance of common stock for cash, shares		2,060,000			824,000
Issuance of common stock for services		$ 1,550	565,380		$ 566,930
Issuance of common stock for services, shares		1,549,840
Convertible debt converted into common stock		$ 1,178	173,823		175,001
Convertible debt converted into common stock, shares		1,179,651
Beneficial conversion feature			120,333		120,333
Derivative liability			101,493		101,493
Issuance of preferred stock for cash	$ 7,500		292,501		300,001
Issuance of preferred stock for cash, shares	750,000
Conversion of preferred stock into common shares	$ (2,500)	$ 417	35,321		33,238
Conversion of preferred stock into common shares, shares	(250,000)	416,667
For Alamo CBD asset acquisition		$ 7,584	1,433,377		1,440,961
For Alamo CBD asset acquisition, shares		7,584,008
Voluntary return of stock by related party		$ (2,500)	2,500
Voluntary return of stock by related party, shares		(2,500,000)
Net loss				(4,412,050)	(4,412,050)
Balance at Dec. 31, 2017	$ 7,500	$ 25,502	$ 7,376,196	$ (8,408,822)	$ (999,624)
Balance, shares at Dec. 31, 2017	750,000	25,503,678

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss from continuing operations	$ (4,412,050)	$ (2,075,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	51,507	51,484
Loss on sale of equipment	73,750	36,627
Loss on debt settlements		131,944
Amortization of original issue discount		22,500
Amortization of debt discount	515,814	438,032
Amortization of debt offering costs		20,000
Impairment loss	1,440,961
Loss on investment in joint venture	250,000
Derivative interest expense		66,980
Change in fair value of embedded derivative liability	442,957	141,756
Stock issued for services - related party	159,930
Stock issued for services	407,000	465,424
Change in operating assets and liabilities:
Accounts receivable	34,853	17,024
Other receivable	7,323
Inventory	2,360	4,641
Prepaid expense	(4,452)	1,697
Accounts payable and accrued expenses	33,236	15,763
Deferred rent	(2,274)	(1,265)
Accrued compensation - officers	(489)
Costs and estimated earnings in excess of billings	(20,155)	224
Net cash used in operating activities	(1,019,729)	(662,170)
Cash flows from investing activities:
Proceeds from the sale of equipment	10,800	10,000
Investment in joint venture	(250,000)
Purchase of equipment and software	(550)	(12,294)
Net cash used in investing activities	(239,750)	(2,294)
Cash flows from financing activities:
Repayments of note payable	(6,787)
Proceeds from convertible notes payable, less offering costs and OID costs paid	500,000	675,000
Repayment of convertible note	(175,000)	(208,223)
Settlement of demand note payable, less OID costs paid	(225,500)
Issuance of preferred stock for cash	300,000	125,000
Issuance of common stock for cash	824,000	50,000
Net cash provided by financing activities	1,216,713	641,777
Decrease cash and cash equivalents	(42,766)	(22,687)
Cash and cash equivalents at beginning of period	78,219	100,906
Cash and cash equivalents at end of period	35,453	78,219
Cash paid during the period for:
Interest	2,469	3,481
Income taxes
Supplemental disclosure of non-cash investing and financing activities:
Beneficial conversion feature	120,333	333,900
Shares issued for debt issuance costs		143,500
Shares issued on conversion of convertible debt		203,351
Unused commitment fee	50,000
Settlement of convertible note into common shares	100,000
Partial conversion of convertible note into common shares	75,000
Conversion of preferred shares into common shares	2,500
Stock issued for the Alamo CBD acquisition	1,440,961
Voluntary return of stock by related party	$ 2,500

Summary of Significant Accounti

Summary of Significant Accounting Policies (Restated)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies (Restated)	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (RESTATED) Nature of Operations and Organization Indoor Harvest Corp. (the “Company,”) is a Texas corporation formed on November 23, 2011. Our principal executive office is located at 5300 East Freeway Suite A, Houston, Texas 77020. On August 3, 2017, we formed Alamo Acquisition, LLC, a wholly owned Texas limited liability company (“Alamo Acquisition Sub”). On August 4, 2017, we consummated a reverse triangular merger pursuant to which Alamo Acquisition Sub acquired all of the outstanding member interests of Alamo CBD, LLC. (“Alamo CBD”), a Texas limited Liability Company. Upon closing of the Alamo Merger, the member interests (“Alamo Survivor Members”) of Alamo CBD were exchanged for 7,584,008 shares of Indoor Harvest’s common stock, the parent company of Alamo Acquisition Sub, and Alamo CBD continued as our surviving wholly-owned subsidiary, and Alamo Acquisition Sub ceased to exist. On October 17, 2018, the Board of Directors (the “Board”) of the Company was notified by the Company’s independent registered public accounting firm, Thayer O’Neal Company, LLC (“Thayer”) that, in July 2018, information came to its attention that led it to investigate whether the Company’s acquisition of Alamo CBD was wrongly accounted for as a business combination. Thayer concluded this investigation on October 17, 2018 and notified the Board that the Company, pursuant to generally accepted accounting principles, should have accounted for the Alamo CBD transaction as an asset acquisition. From inception until August 4, 2017, the Company provided full service, state of the art design-build, engineering, procurement and construction services to the indoor and vertical farming industry. The Company provided production platforms, mechanical systems and complete custom designed build outs for both Controlled Environment Agriculture (“CEA”) and Building Integrated Agriculture (“BIA”), for two unique industries, produce and cannabis. In mid-2016, the Company began efforts to separate its produce and cannabis related operations due to ongoing feedback from both clients and potential institutional investors. It was determined that the Company’s involvement in the cannabis industry was creating conflicts for clients and potential institutional investors wishing to work with the Company from the produce industry due to the public perception and political issues surrounding the cannabis industry. By late-2016, the Company had decided to cease actively selling its products and services to the vertical farming industry and to focus on utilizing the Company’s developed technology and methods for the cannabis industry. On August 4, 2017, the Company ceased actively supporting business development of vertical farms for produce production. Basis of Presentation The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). It is management’s opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, the estimate of percentage of completion on construction contracts in progress at each reporting period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities. Principles of Consolidation The consolidated financial statements include the accounts of Indoor Harvest Corp. and its wholly-owned subsidiary, Alamo CBD. All significant inter-company accounts and transactions have been eliminated in consolidation. Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less to be cash and cash equivalents. Accounts Receivable and Work in Progress Work in progress consists of costs recorded and revenue earned on projects recognized on the percentage of completion method for work performed on contracts in progress at September 30, 2017, and December 31, 2016. The Company records revenue based on contractual agreements entered into at the inception of construction contracts. Amounts are payable from customers based on milestones established in each contract. Amounts are billed at milestone completion and are reflected as accounts receivable when billed. Costs and estimated earnings are accumulated on projects in process and compared to amounts billed based on the percentage of completion method of accounting (cost to cost). Costs incurred in excess of amounts billed and related profit recognized are reflected as an asset on the balance sheet as costs and estimated earnings in excess of billings. Unearned billings are reflected in the balance sheet as a liability as billings in excess of costs and estimated earnings on projects in process (See Note 9). Inventories Inventory consists primarily of raw materials and packaging materials and is valued at the lower of cost or market. Cost is determined using the weighted average method and the average cost is recomputed after each inventory purchase or sale. Inventory is periodically reviewed to identify obsolete or damaged inventory and impaired values. Inventory is comprised of raw materials such as steel for our framing systems and packaging materials such as boxes and pallets. Revenue Recognition The Company recognizes revenue on arrangements in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 605, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company will generate revenue from the design and installation of the equipment and licensing of technology. Revenue from construction contracts are reported under the percentage of completion method for financial statement purposes. The estimated revenue for each contract reflected in the financial statements represent that percentage of estimated total revenue that costs incurred to date bear to estimated total costs, based on the Company’s current estimates. With respect to contracts that extend over one or more accounting periods, revisions in costs and revenue estimates during the work are reflected in the period the revisions become known. When current estimates of total contract costs indicate a loss, provision is made for the entire estimated loss. The asset, “costs and estimated earnings in excess of billings on uncompleted contracts,” represents revenues recognized in excess of amounts billed. The liability, “Estimated earnings on uncompleted contracts,” represents billings in excess of revenues recognized. Billing practices for these projects are governed by the contract terms of each project based upon actual costs incurred, achievement of milestones, or pre-agreed schedules. Billings do not necessarily correlate with revenue recognized under the percentage of completion method of accounting. Except for claims and change orders that are in the process of being negotiated with customers, unbilled work is usually billed during normal billing processes following achievement of the contractual requirements. Stock Based Compensation The Company recognizes stock-based compensation in accordance with ASC 718-10, Stock Compensation. ASC 718-10 focuses on transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus in which an entity obtains employee services in stock-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award (with limited exceptions). Loss per Share Basic earnings per share amounts are calculated based on the weighted average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the weighted average numbers of shares of common stock outstanding for the periods, including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. Since Indoor Harvest has incurred losses for all periods, the impact of the common stock equivalents would be anti- dilutive and therefore are not included in the calculation. Fair Value of Financial Instruments We adopted accounting guidance for financial and non-financial assets and liabilities (ASC 820). The adoption did not have a material impact on our results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share- based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: ● Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. ● Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. ● Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Income Taxes The Company accounts for income taxes pursuant to FASB ASC 740—Income Taxes, which requires recognition of deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. The Company provides for deferred taxes on temporary differences between the financial statements and tax basis of assets using the enacted tax rates that are expected to apply to taxable income when the temporary differences are expected to reverse. ASB ASC 740 establishes a more-likely-than-not threshold for recognizing the benefits of tax return positions in the financial statements. Also, the statement implements a process for measuring those tax positions that meet the recognition threshold of being ultimately sustained upon examination by the taxing authorities. There are no uncertain tax positions taken by the Company on its tax returns. The Company files tax returns in the U.S. and states in which it has operations and is subject to taxation. Tax years subsequent to 2008 remain open to examination by U.S. federal and state tax jurisdictions. Tax years 2017, 2016, 2015, 2014, and 2013, remain subject to examination by the IRS and respective states. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Reform Act”). We recognize the impact of tax legislation in the period in which the law is enacted. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the effect of the changes in the Tax Reform Act. Consistent with that guidance, we recognized provisional amounts based upon our interpretation of the tax laws and estimates which require significant judgments. The actual impact of these tax laws may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in our interpretations and assumptions, additional guidance that may be issued by the government and actions we may take as a result of these enacted tax laws. Any adjustments recorded to the provisional amounts will be included in income from operations as an adjustment to tax expense. Property and Equipment Property and equipment is recorded at cost and depreciated or amortized using the straight-line method over the estimated useful life of the asset or the underlying lease term for leasehold improvements, whichever is shorter. The estimated useful life by asset description is noted in the following table: Asset description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * * The shorter of 5 years or the life of the lease. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in other income. Goodwill In accordance with ASC 350 Goodwill is not amortized but evaluated for impairment annually or more often if indicators of a potential impairment are present. Intangible Assets (Restated) In accordance with ASC 350 Goodwill and Other Intangible Assets, indefinite-lived intangible assets are not amortized but are evaluated for impairment annually or more often if indicators of a potential impairment are present. Indefinite-lived intangible assets consist of the Company’s domain name. Finite-lived intangible assets include software and is amortized over a 3 to 5-year period. The Company recognized $1,440,961 and $0 for impairment charges taken during the year ended December 31, 2017 and 2016, respectively. Patent and Patent Application Expenses Although the Company believes that its patent and underlying technology will have continuing value, the amount of future benefits to be derived from the patent is uncertain. Therefore, patent costs are expensed as incurred. Research and Development Research and development expenditures are charged to expense as incurred. Advertising Expense Advertising and promotional costs are expensed as incurred. Reclassifications Certain expense items have been reclassified in the statement of operations for the year ended December 31, 2016, to conform to the reporting format adopted for the year ended December 31, 2017. Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect as of the date of the issuance of these financial statements. The following pronouncements may significantly impact future reporting of financial position and results of operations. Management is currently assessing implementation. The FASB has issued Accounting Standards Update (ASU) No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, clarifying the definition of a business. The amendments affect all companies and other reporting organizations that must determine whether they have acquired or sold a business. For public companies, the amendments are effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The FASB has issued its new lease accounting guidance in Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: ● A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and ● A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ● Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. ● The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (i.e., January 1, 2019, for a calendar year entity). The FASB has issued Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments are intended to improve the accounting for employee share-based payments and affect all organizations that issue share-based payment awards to their employees. Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. For public companies, the amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For private companies, the amendments are effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Early adoption is permitted for any organization in any interim or annual period. The FASB has issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. The amendments clarify the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendments do not change the core principle of the guidance in Topic 606. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. Public entities should apply the amendments for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). Early application for public entities is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The effective date for nonpublic entities is deferred by one year. Derivative Liability The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2017 and December 31, 2016, the Company did not have any derivative instruments that were designated as hedges. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

Restatement of Financial Statem

Restatement of Financial Statements	12 Months Ended
	Dec. 31, 2017
Accounting Changes and Error Corrections [Abstract]
Restatement of Financial Statements	NOTE 2 - RESTATEMENT OF FINANCIAL STATEMENTS On October 17, 2018, the Board was notified by Thayer that, in July 2018, information came to its attention that led it to investigate whether the Company’s acquisition of Alamo CBD was wrongly accounted for as a business combination. Thayer concluded this investigation on October 17, 2018 and notified the Board that the Company, pursuant to generally accepted accounting principles, should have accounted for the Alamo CBD transaction as an asset acquisition. The Company had recorded $1,440,961 for Goodwill from the acquisition of Alamo CBD), from the issuance of 7,584,008 shares of common stock valued at $1,440,961. The Company has determined this amount should be restated as an impairment loss of intangible assets. The effects of the adjustments on the Company’s previously issued financial statements as at December 31, 2017 and for the year ended December 31, 2017 are summarized as follows: Originally Restatement Statements of Operations Reported Adjustment As Restated For the twelve months ended December 31, 2017 Impairment loss from Goodwill $ 1,440,961 $ (1,440,961 ) $ - Impairment loss of intangible assets $ - $ 1,440,961 $ 1,440,961 Total operating expenses $ 1,440,961 $ - $ 1,440,961

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 3 - GOING CONCERN As reflected in the accompanying financial statements, the Company had a net loss of $4,412,050, net cash used in operations of $1,269,729 and has an accumulated deficit of $8,408,822, for the year ended December 31, 2017. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on Management’s plans which include potential asset acquisitions, mergers or business combinations with other entities, further implementation of its business plan and continuing to raise funds through debt or equity financings. The Company will likely rely upon related party debt or equity financing in order to ensure the continuing existence of the business. The business plan of the Company is to engage in the design, development, marketing and direct-selling of commercial grade aeroponics fixtures and supporting systems for use in urban Controlled Environment Agriculture (“CEA”) and Building Integrated Agriculture (“BIA”). During the next twelve months, the Company’s strategy is to: complete ongoing product development; commence product marketing, product assembly and sales; construct a demonstration CEA and BIA farm; and offer design-build services. The Company’s long-term strategy is to direct sale, license and franchise their patented technologies and methods. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 4 - PROPERTY AND EQUIPMENT Property and equipment consist of the following at December 31, 2017 and 2016: Classification 2017 2016 Furniture and equipment $ 11,666 $ 123,829 Tooling equipment — 27,015 Leasehold improvements 38,717 57,780 Computer equipment 3,019 8,933 Research and development lab — 59,482 Total 53,402 277,039 Less: Accumulated depreciation (28,779 ) (118,621 ) Property and equipment, net $ 24,623 $ 158,418 Depreciation expense for the years ended December 31, 2017 and 2016, totaled $49,797 and $51,484, respectively. During the year ended December 31, 2017, the Company sold $23,467 of equipment in exchange for $10,800. In addition, the Company wrote off $201,651 of equipment primarily related to the fabrication of vertical farming equipment for produce. As a result of these disposals, the Company recorded a loss of $73,750 that was recorded in the Condensed Statement of Operations within general and administrative expenses. During the year ended December 31, 2016 the Company sold $46,626 of other assets which were equipment in exchange for $10,000 and recorded a loss on the sale of equipment of $36,626. The Company also placed in service $2,157 from other assets.

Commitments & Contingencies

Commitments & Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	NOTE 5 - COMMITMENTS & CONTINGENCIES On February 20, 2014, the Company signed a 60-month lease on a 10,000 sq. ft. office/warehouse facility and paid a deposit of $12,600. The monthly base rent is $4,200 increasing 6% every two years for the term of the lease. The property is adequate for all of the Company’s currently planned activities. Deferred rent payable at December 31, 2017 was $6,239. Deferred rent payable is the sum of the difference between the monthly rent payment and the straight-line monthly rent expense of an operating lease that contains escalated payments in future periods. Rent expense for the years ended December 31, 2017 and 2016, were: 2017 2016 Rent expense $ 52,550 $ 51,403 At December 31, 2017, rental commitments are as follows: Years Ending December 31, Amount 2018 $ 55,560 2019 18,876 Total $ 74,436

Asset Acquisition (Restated)

Asset Acquisition (Restated)	12 Months Ended
	Dec. 31, 2017
Business Combinations [Abstract]
Asset Acquisition (Restated)	NOTE 6 – ASSET ACQUISITION (RESTATED) Alamo CBD, LLC On January 3, 2017, the Company signed a binding LOI with Alamo CBD to enter discussions to combine and create a medical cannabinoids pharmaceutical group. On August 3, 2017, we formed Alamo Acquisition, LLC, a wholly owned Texas limited liability company (“Alamo Acquisition Sub”). On August 4, 2017, we consummated a reverse triangular merger pursuant to which Alamo Acquisition Sub acquired all of the outstanding member interests of Alamo CBD, LLC. (“Alamo CBD”), a Texas limited Liability Company. Upon closing of the Alamo Merger, the member interests (“Alamo Survivor Members”) of Alamo CBD were exchanged for 7,584,008 shares of Indoor Harvest’s common stock, the parent company of Alamo Acquisition Sub, and Alamo CBD continued as our surviving wholly-owned subsidiary, and Alamo Acquisition Sub ceased to exist. As discussed above, management is now accounting for the acquisition of Alamo CBD as an acquisition of assets (and not a business combination). In addition to the foregoing, following the closing of the transaction, and Alamo CBD being successfully awarded a provisional or full license to produce and dispense cannabis in the State of Texas, Indoor Harvest will issue to the individual Alamo Survivor Members, an additional Eight Million Five Hundred Thousand Dollars ($8,500,000) of newly-issued shares of common stock of Indoor Harvest, par value $0.001, based upon the three (3) day average closing price of the Company’s common stock, as quoted on the OTCQB, prior to the time of issuance. Additionally, upon Alamo CBD successfully being registered and licensed by the DEA to produce and dispense cannabis under federal law, Indoor Harvest will issue to the individual Alamo Survivor Members, an additional Two Million Five Hundred Thousand Dollars ($2,500,000) cash payment, or newly-issued shares of common stock of Indoor Harvest, par value $0.001, based upon the three (3) day average closing price of the Company’s common stock, as quoted on the OTCQB, prior to the time of issuance, at the option of the individual Alamo Survivor Member. A combination of cash and common stock may be elected by Alamo Survivor Member individually. On August 8, 2017, Chad Sykes, the Company’s Founder and Chief of Cultivation, returned 2,500,000 shares of common stock to the Company. Mr. Sykes voluntarily returned such shares in order to prevent dilution to the Company’s shareholders as a result of the merger and in order to facilitate the merger. The return of common stock by Chad Sykes was a non-cash transaction and reduces the common stock outstanding as of December 31, 2017. On September 6, 2017, the Company issued an aggregate of 7,584,008 shares of common stock to the members of Alamo CBD related to the Merger. The Company recorded intangible assets at a fair value of $1,440,961 ($0.19 per share) based upon closing price per share of the Company’s common stock on the date the stock was issued. The intangible assets acquired in the transaction, were Alamo CBD’s pending provisional or full license to produce and dispense cannabis in the State of Texas. During the quarter ended September 30, 2017, the Company’s management decided to impair the intangible assets created by the Alamo CBD transaction, as there are doubts regarding when a license may be issued, as the license is pending and may or may not ever be issued, and whether upon receipt of the license if it will lead to significant positive cash flows. The Company recorded an impairment loss of intangible assets of $1,440,961 in the Statement of Operations for the year ended December 31, 2017. Contractual Joint Venture with Alamo CBD and Vyripharm Enterprises, LLC On March 23, 2017, Indoor Harvest entered into a Contractual Joint Venture Agreement by and between Vyripharm Enterprises, LLC (“Vyripharm”) and Alamo CBD, collectively the parties, pursuant to which the parties agreed to participate in an unincorporated joint venture (the “Joint Venture”) for the following business purposes: ● The parties would work together to enhance the ability of Alamo CBD to apply for and obtain licensure, or a permit, to grow and/or dispense marijuana products for medical and/or consumer use, as the case may be: i. In Texas, pursuant to the Texas Compassionate Use Act, as may be amended; ii. In Colorado, pursuant to recent Colorado legislation permitting foreign ownership of entities that grow and/or dispense marijuana products for medical and/or consumer use; and iii. Pursuant to recent United States Drug Enforcement Administration regulations which expand the opportunities for entities providing research involving marijuana and its chemical constituents, as referenced in 21 U.S.C. 822(a)(1) and 21 U.S.C. 823(a), et. seq. ● To establish Alamo CBD as a supplier of a variety of medical use cannabis oil to Vyripharm for Vyripharm’s use in conducting research and development to create novel pharmaceutical and radiopharmaceutical compounds designed to image and treat certain debilitating diseases including, but not limited to epilepsy, post-traumatic stress disorder, Alzheimer’s, ALS, and other neurodegenerative diseases; and to establish Indoor Harvest as the project developer and engineering, procurement and construction group, in which Indoor Harvest is responsible for costs and efforts related to Alamo CBD’s efforts to become licensed under the Texas Compassionate Use Act and to meet its obligations under this Joint Venture agreement. The initial term of the Joint Venture was to be five (5) years following the effective date, and the Joint Venture Agreement could be extended beyond this initial term by mutual consent of the parties. Pursuant to the Joint Venture terms, the Company agreed to contribute a total of $5,000,000 on the basis of $1,000,000 per year for each of the first five (5) years of the Initial Term. Should the Company fail to make payment under the Joint Venture, the agreement would terminate and neither party would have further obligation to the other. The Company paid an initial down payment of $250,000 under the Joint Venture Agreement on March 30, 2017. Background for the Contractual Joint Venture The purpose of the above-described change in business and Joint Venture was twofold, as follows: ● It would separate the Company’s cannabis and produce related operations, as we indicated was previously a goal. ● It would put in place all elements necessary for the resulting Joint Venture, of which the resulting public reporting company would have a significant on-going interest, to become a registered producer under the federal CSA to produce cannabis. As of December 1, 2017, only one entity, the University of Mississippi can legally manufacture Cannabis to supply researchers involved in the various studies about using cannabis to treat maladies such as PTSD or Epilepsy. On August 12, 2016, the DOJ and the DEA issued a policy statement on cannabis issues, as follows: ● It is well known that the DOJ and DEA have said that cannabis would continue to be classified as a Schedule 1 drug, like heroin. ● It is not so well known that the DOJ and DEA also reset the policy regarding entities that could legally manufacture cannabis to supply researchers involved in various clinical studies using cannabis to treat maladies such as PTSD or Epilepsy. According to the policy statement, the purpose of this policy reset is to increase the number of U.S. entities registered under the CSA to grow (manufacture) cannabis to supply researchers on the effectiveness of medical grade cannabis in treating these and other maladies. The CSA under subsection 823(a)(1) provides, DEA is obligated to register only the number of bulk manufacturers of a given schedule I or II controlled substance that is necessary to “produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical, scientific, research, and industrial purposes.” The policy statement (Federal Register Vol. 81) provided additional explanation on how the DEA would evaluate applications for such registration consistent with the CSA and the obligations of the United States under the applicable international drug control treaty. The Company had reviewed these guidelines and believed all applicable requirements which could not be met by the Company alone would be met by the following: ● Our previous Cannabis Pilot Agreement and completed technology trials with Canopy Growth Corporation, a Canadian licensed producer under the Marihuana for Medical Purposes Regulations, had demonstrated that our aeroponic technology could augment and improve the quality and production of cannabis for use in cannabis research. ● We believed that the proposed combination with Alamo and the joint venture with Vyripharm Enterprises, LLC, in which the Company would have an equity interest due to its combination with Alamo, would meet all the additional guidelines and conditions set forth regarding the expected required experience in handling of a controlled substance and its related research with cannabis for pharmaceutical use that is one of the conditions of the policy statement. Voluntary Default of Joint Venture and Status of Application with DPS As published in the Texas Department of Public Safety (“DPS”) Self-Evaluation Report, on page 543, question (D), dated September 29, 2017, the DPS originally interpreted the statute as requiring a market-based system by which the number and location of licensees are determined by market factors rather than by regulation – as not mandating or limiting the number of licensed distributors. It was originally understood that the applicants would be required to satisfy certain basic requirements prior to licensure, and the ability to maintain compliance with DPS guidelines will be evaluated through on-going audits and inspections. In late 2016, the DPS modified its approach to restrict the number of licenses to three. This necessitated the development of a competitive review process, where three applicants were conditionally approved based on the review of the submitted application materials. Upon successful onsite inspection of their facilities, qualified applicants will be issued licenses. Because of this competitive review process, the Joint Venture group placed 16th out of 43 applicants and its application is currently considered pending by the DPS. On June 30, 2017, the Company, Alamo CBD and Vyripharm entered into discussions to amend and extend the payment terms under the Joint Venture Agreement due to the group not being awarded one of the three initial provisional licenses to produce cannabis in Texas under the TCUP. On August 7, 2017, after negotiations, the Company advised Vyripharm that it intended to voluntarily default on the Joint Venture Agreement and the Company wrote off the $250,000 down payment towards the Joint Venture investment and there is no further obligation by either party under the terms of the Joint Venture. The Company’s management determined that without a license to produce cannabis, the Company would not be able to fully utilize the intent of the Joint Venture partnership and the Company would be financially burdened by the ongoing Joint Venture terms. Both parties agreed that this decision would not impair either party’s ability to pursue a Joint Venture in the future, after the Company, or Alamo CBD, obtained license to produce cannabis. The Company is a member and is working with the Medical Cannabis Association of Texas and expects both lobbying and legislative efforts currently being undertaken to result in the program being expanded, additional permits being awarded, and new legislation being introduced in 2019 to allow for a separate permitting process to conduct cannabis research in line with the CSA. There is no guarantee that these efforts will result in the Company obtaining a license or permit to produce cannabis in Texas or that legislation will be adopted allowing a separate licensing or permitting process for research purposes. As part of the Company’s annual impairment evaluation, management decided to impair the goodwill created by the Alamo Merger as there are doubts regarding when a license may be issued, as the license is pending and may or may not ever be issued, and whether upon receipt of the license if it will lead to significant positive cash flows. The Company recorded an impairment of goodwill in the Statement of Operations for the year ended December 31, 2017 of $1,440,961.

Loan Payable

Loan Payable	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Loan Payable	NOTE 7 - LOAN PAYABLE On June 5, 2015, the Company entered into a five-year loan agreement totaling $36,100. The loan carries an interest rate of 10.25%. During the year ended December 31, 2017 the Company repaid $6,789 of the principal and the remaining balance is $20,343, of which $7,520 is recorded as a current note payable. Year Ending December 31, Amount 2018 $ 7,520 2019 8,328 2020 4,495 $ 20,343

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2017
Risks and Uncertainties [Abstract]
Concentrations	NOTE 8 - CONCENTRATIONS At December 31, 2017 and December 31, 2016, the Company had concentrations of accounts receivable of: Customer December 31, 2017 December 31, 2016 Tweed, Inc. 0 % 100 % For the years ended December 31, 2017 and December 31, 2016, the Company had a concentration of sales of: 2017 2016 Customer Revenue ($) Percentage Revenue ($) Percentage Tweed (Canopy Growth Corporation) $ — — % $ 80,620 50 % ER Michigan (Michigan State University) $ — — % $ 28,385 18 % Urbanika Farms $ — — % $ 27,600 17 % University of Arizona CEAC $ — — % $ 18,626 11 % GSS Colorado $ — — % $ 5,000 2 % PH Research Platform $ — — % $ 3,765 2 % Total $ — — % $ 163,996 100 % For the year ended December 31, 2017, the Company had a purchasing concentration of $3,897 with Illumitex, LLC, a manufacturer largely specializing in the production and development of LED lights for indoor and vertical farming totaling 74%. For the year ended December 31, 2016, the Company had a purchasing concentration of $29,500 with 3rd Coast Pump & Equipment, LLC, a manufacturer of custom specialty pump and control packages totaling 37%.

Intangible Assets (Restated)

Intangible Assets (Restated)	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets (Restated)	NOTE 9 - INTANGIBLE ASSETS (RESTATED) There were no impairment charges taken for the domain name during the year ended December 31, 2017 and December 31, 2016. Intangible assets consist of the following at December 31, 2017 and December 31, 2016: Classification 2017 2016 Domain name $ 2,000 $ 2,000 Facilities Manager’s Package Online 1,022 1,022 MLC CD Systems (software) 7,560 7,560 Total 10,582 10,582 Less: Accumulated amortization (4,690 ) (2,978 ) Intangible assets, net $ 5,892 $ 7,604 The Company recognized $1,440,961 and $0 for impairment charges taken during the nine months ended September 30, 2017 and 2016, respectively, for the acquisition of Alamo CBD assets.

Work in Process

Work in Process	12 Months Ended
	Dec. 31, 2017
Contractors [Abstract]
Work in Process	NOTE 10 - WORK IN PROCESS Work in progress as of December 31, 2017 and December 31, 2016, consisted of the following: Description 2017 2016 Costs incurred on uncompleted contracts $ — $ 80,620 Estimated earnings — — Less: Billings to date — (100,775 ) Total — (20,155 ) Reflected in balance sheet as: Costs and estimated earnings in excess of billings on contracts in process $ — $ — Billings in excess of costs and estimated earnings on contracts in process — 20,155 Total $ — $ 20,155

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 11 - FAIR VALUE MEASUREMENTS Carrying amounts reported on the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value due to their relatively short maturity. Debt classified as Level 2 in the fair value hierarchy represent note payable, net of debt discount, of $0 and $209,786 at December 31, 2017 and December 31, 2016, respectively, and convertible notes payable of $668,912 and $122,383 at December 31, 2017 and December 31, 2016, respectively. Debt classified as Level 3 in the fair value hierarchy represents derivative liability of $554,916 and $0 at December 31, 2017 and December 31, 2016, respectively.

Debt and Convertible Loan Payab

Debt and Convertible Loan Payable	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Debt and Convertible Loan Payable	NOTE 12 - DEBT AND CONVERTIBLE LOAN PAYABLE On March 20, 2017, the Company entered into a settlement agreement relating to a promissory note with Chuck Rifici Holdings, Inc originally dated September 26, 2016 (“Rifici Note”). The Company settled the amount owed by paying $269,498 in cash. The Company was released from any further liability under this Rifici Note upon payment of this amount. On March 20, 2017, the Company entered into a settlement agreement relating to two (2) promissory notes with FirstFire Global Opportunities Fund, LLC dated October 19, 2016 and December 12, 2016. Pursuant to the settlement, the Company paid the holder an aggregate of $252,917 in cash and issued 333,333 shares of common stock with a fair value of $100,000 based upon the conversion price of $0.30 per share. The Company was released from any further liability under this FirstFire Global Opportunities Fund, LLC note upon payment of this amount. On March 24, 2017, the Company entered into a securities purchase agreement with Tangiers Global, LLC (“Tangiers”) relating to the issuance and sale of notes (“Note 1”) in the aggregate principal amount of up to $550,000, which includes a 10% original issue discount. Note1 is convertible into shares of common stock at a price equal to $0.30 per share; provided, however that if Note 1 is not retired on or before the maturity date, defined in Note 1 as a “Maturity Default” the conversion price shall be adjusted to be equal to the lower of: (i) $.30 or (ii) 65% multiplied by the lowest trading price of the Company’s common stock in the fifteen (15) consecutive trading day period immediately preceding the date that the Company receives a notice of conversion. The Tangiers Note carries interest on the unpaid principal amount at the rate of 8% per annum and is due and payable eight months from the effective date of each payment. As of December31, 2017, the balance under Note 1 is $519,000, which includes $44,000 guaranteed interest. As of December 31, 2017, Note 1 can be converted into 3,280,255 shares of the Company’s common stock. On October 12, 2017, the Company entered into an Investment Agreement with Tangiers. Pursuant to the terms of the Investment Agreement, Tangiers committed to purchase up to $2,000,000 of our common stock over a period of up to 36 months. From time to time during the 36-month period commencing from the effectiveness of the registration statement, we may deliver a put notice to Tangiers which states the dollar amount that we intend to sell to Tangiers on a date specified in the put notice. The maximum investment amount per notice must be no more than 200% of the average daily trading dollar volume of our common stock for the eight (8) consecutive trading days immediately prior to date of the applicable put notice and such amount must not exceed an accumulative amount of $250,000. The minimum put amount is $5,000. The purchase price per share to be paid by Tangiers will be the 80% of the of the average of the two lowest closing bid prices of the common stock during the pricing period applicable to the put notice, provided, however, an additional 10% will be added to the discount of each put if (i) we are not DWAC eligible and (ii) an additional 15% will be added to the discount of each put if we are under DTC “chill” status on the applicable date of the put notice. The Company issued a fixed convertible promissory note to Tangiers for the principal sum of $50,000 as a commitment fee for the Investment Agreement. The promissory note maturity date is May 12, 2018. The principal amount due under Note 2 can be converted by Tangiers any time, into shares of the Company’s common stock at a conversion price of $0.1666 per share. Upon a “Maturity Default,” which is defined in Note 2 as the event in which Note 2 is not retied prior to its maturity date, Tangiers’ conversion rights under Note 2 would be adjusted such that the conversion price would be the lower of (i) $0.1666 or (ii) b) 65% of the average of the two lowest trading prices of the Company’s common stock during the 10 consecutive trading days prior to the date on which Tangiers elects to convert all or part of the note. As of December 31, 2017, the balance under Note 2 is $55,000, which includes $5,000 guaranteed interest. As of December 31, 2017, Note 2 can be converted into 300,120 shares of the Company’s common stock. On October 17, 2017, the Company converted debt and accrued interest, totaling $30,000 into 329,670 shares of common stock. On December 18, 2017, the Company converted debt and accrued interest, totaling $45,000 into 516,648 shares of common stock. On October 10, 2017, the Company executed Amendment #1 to the Tangiers Note for a final draw of $250,000 payment plus a 10% original issue discount (“Note 2”). Amendment #1 modified the maturity date for the Tangier Note from eight months to six months from the effective date of each payment. All other terms and conditions of the Tangiers Note remain effective. The execution of the amendment to Note 1 on October 10, 2017 caused the Company to default on the first draw due under Note 1 due to the acceleration of the maturity date. The default allows Tangiers to demand payment in cash equal to 150% of the outstanding principal and interest, which is automatically added to the outstanding principle, and convert all or a portion of the outstanding principal into shares of common stock of the Company. The default conversion rate of Note 1 is now the lower of the conversion rate then in effect or 65% of the lowest trading price for the 15 days prior to Tangiers’ notice of conversion. As of March 13, 2018, Tangiers has informed the Company that they have elected at this time not to enforce the default interest rate under Note 1 and also not to enforce the fees, reserving its rights to enforce the foregoing in their discretion. Other than the foregoing, none of the above listed notes are currently in default. For the year ended December 31, 2017 and December 31, 2016, the Company accrued $49,000 and $10,334, respectively, in accrued interest related to outstanding the note. Debt Discount and Original Issuance Costs During the year end December 31, 2017 and 2016, the Company recorded debt discounts totaling $383,786 and $417,834, respectively. The debt discount amount consists of debt discount due to beneficial conversion features, warrant, original issue costs, and debt issue costs. The debt discounts recorded in 2017 and 2016, pertain to beneficial conversion feature on the convertible notes. The notes are required to be bifurcated and reported at fair value on the date of grant. The Company amortized $466,862 and $265,217 to interest expense during the years ended December 31, 2017 and 2016, as follows: 2017 2016 Debt discount, beginning of period $ 152,617 $ — Additional debt discount and debt issue cost 383,786 417,834 Amortization of debt discount and debt issue cost (466,862 ) (265,217 ) Debt discount, end of period $ 69,541 $ 152,617 Debt Issuance Costs During the year ended December 31, 2017 and 2016, the Company paid debt issue costs totaling $0 and $20,000, respectively. During the years ended December 31, 2017 and 2016, the Company amortized $0 and $20,000 of debt issue costs, respectively. The following is a summary of the Company’s debt issue costs for the years ended December 31, 2017 and 2016: 2017 2016 Debt discount, beginning of period $ — $ — Additional debt discount — 20,000 Amortization of debt discount — (20,000 ) Debt discount, end of period $ — $ —

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 13 - DERIVATIVE LIABILITIES The Company identified the conversion features embedded within its convertible debts as financial derivatives. The Company has determined that the embedded conversion option should be accounted for at fair value. The following schedule shows the change in fair value of the derivative liabilities at year end December 31, 2017: Derivative liabilities - December 31, 2016 $ — Add fair value at the commitment date for convertible notes issued during the current year 213,453 Less derivatives due to conversion (101,493 ) Fair value mark to market adjustment for derivatives 442,957 Derivative liabilities - December 31, 2017 554,917 Less : current portion (554,917 ) Long-term derivative liabilities $ — The following schedule shows the change in fair value of the derivative liabilities at year end December 31, 2016: Derivative liabilities - December 31, 2015 $ — Add fair value at the commitment date for convertible notes issued during the current year 270,331 Less derivatives due to conversion (412,086 ) Fair value mark to market adjustment for derivatives 141,755 Derivative liabilities - December 31, 2017 — Less : current portion — Long-term derivative liabilities $ — The Company recorded the debt discount to the extent of the gross proceeds raised and expensed immediately the remaining value of the derivative as it exceeded the gross proceeds of the note. The Company recorded derivative interest expenses for the year ended December 31, 2017 of $0. The fair value at the commitment and re-measurement dates for the Company’s derivative liabilities were based upon the following management assumptions during the current quarter: Assumption Commitment Date Remeasurement Date Expected dividends: — % — % Expected volatility: 134 % 130 - 169 % Expected term (years): 0.42 0.15 - 0.36 years Risk free interest rate: 1.19 % 1.25 - 1.39 %

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 14 - RELATED PARTY TRANSACTIONS On January 16, 2017, the Company issued 145,740 shares of common stock related to a Director Agreement with Pawel Hardej. The Company recorded fair value of $64,126 ($0.44 per share) based upon the most recent trading price per share of the Company’s stock. On January 16, 2017, the Company issued 41,640 shares of common stock related to a Director Agreement with John Zimmerman. The Company recorded fair value of $18,322 ($0.44 per share) based upon the most recent trading price per share of the Company’s stock. On January 16, 2017, the Company issued 62,460 shares of common stock related to a Director Agreement with John Choo. The Company recorded fair value of $27,482 ($0.44 per share) based upon the most recent trading price per share of the Company’s stock. On August 8, 2017, Chad Sykes, the Company’s Founder and Chief of Cultivation, returned 2,500,000 shares of common stock to the Company. Mr. Sykes voluntarily returned such shares in order to prevent dilution to the Company’s shareholders as a result of the Alamo Merger and in order to facilitate the merger. The return of common stock by Chad Sykes was a non-cash transaction and reduces the common stock outstanding as of December 31, 2017. On August 9, 2017, Chad Sykes, the Company founder, tendered his resignation as a Director and member of the Board of Directors as part of the Company’s merger agreement with Alamo CBD. On August 9, 2017, John Choo tendered his resignation as a Director and member of the Board of Directors as part of the Company’s merger agreement with Alamo CBD. On August 9, 2017, Pawel Hardej tendered his resignation as a Director and member of the Board of Directors as part of the Company’s merger agreement with Alamo CBD. On August 9, 2017, John Seckman was elected a Director and member of the Board of Directors. On November 1, 2017, John Seckman resigned as a Director of the Company and as a member of the Board of Directors, effective December 4, 2017. Mr. Seckman’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies (including accounting or financial policies) or practices, the Company’s management or the Board. Mr. Seckman’s resignation was due to time constraints based on new business and increasing demands of John Seckman and Associates, of which Mr. Seckman is principal. On August 9, 2017, we entered into a Director Agreement with Rick Gutshall. The Company agreed to reimburse the Director for reasonable travel and other incidental expenses incurred by the Director in performing his services and attending meetings as approved in advance by the Company. On August 9, 2017, we entered into a Director Agreement with Annette Knebel. The Company agreed to reimburse the Director for reasonable travel and other incidental expenses incurred by the Director in performing his services and attending meetings as approved in advance by the Company. On August 9, 2017, we entered into a Director Agreement with Dr. Lang Coleman. The Company agreed to reimburse the Director for reasonable travel and other incidental expenses incurred by the Director in performing his services and attending meetings as approved in advance by the Company. On September 6, 2017, the Company issued 2,957,763 shares of common stock to Dr. Lang Coleman, Director, related to the merger of the Company and Alamo CBD. The Company recorded fair value of $561,975 ($0.19 per share) based upon the most recent trading price per share of the Company’s stock. On September 6, 2017, the Company issued 758,401 shares of common stock Rick Gutshall, former Interim-Chief Executive Office, former Chief Financial Officer, and Director, related to the merger of the Company and Alamo CBD. The Company recorded fair value of $144,096 ($0.19 per share) based upon the most recent trading price per share of the Company’s stock. On September 15, 2017, the Company issued 250,000 shares of common stock related to an Employment Agreement with Annette Knebel, Chief Financial Officer and Director and former Chief Accounting Officer. The Company recorded fair value of $50,000 ($0.20 per share) based upon the most recent trading price per share of the Company’s stock. On May 9, 2016, the Company entered into a Director Agreement with Pawel Hardej. The Company will reimburse the Director for reasonable travel and other incidental expenses incurred by the Director in performing his services and attending meetings as approved in advance by the Company. The Company shall award to the Director 166,560 shares of common stock over a two-year period as directed in the Director Agreement. As of December 31, 2016, the Company issued 20,820 shares of common stock having a fair value of $13,512 ($0.65/share) based upon the most recent trading price per share of the Company’s common stock (See Note 11). On April 8, 2016 the Company entered into an employment agreement with John Zimmerman, to serve as a Vice President of Business Development. The term of the agreement will continue until April 8, 2017, unless the employment is sooner terminated by the Board of Directors. As compensation for services, the employee will receive 100,000 shares of common stock and a percentage of closed projects as follows: ● 5% on Purchase Orders (facilities and production finishing hardware) minus taxes, fees and shipping for sole sourced projects that lead to a signed Design Build Agreement. ● 5% of Facilities portion of Purchase Order only on signed Design Build agreements brought in from Authorized Dealers. ● Discretionary % split agreed to by Executive on a case-by-case basis for supporting services he chooses to bring into closing an agreement. ● Compensation payments dispersed at the same % rate as the contractually agreed client payments schedule is received from the client/finance group (i.e.: 5% down, 50% at Purchase Order, 45% at shipping, etc.) On April 8, 2016, we issued 100,000 shares of common stock related to an Executive Employment Agreement with John Zimmerman. The Company recorded fair value of $54,500 ($0.545/share) based upon the most recent trading price per share of the Company’s stock (See Note 11). On March 1, 2015, the Company entered into a Director Agreement with William Jamieson. The Company will reimburse the Director for reasonable travel and other incidental expenses incurred by the Director in performing his services and attending meetings as approved in advance by the Company. The Company shall award to the Director 166,560 shares of common stock pursuant to the Company’s 2015 Stock Incentive over a two-year period as directed in the Director Agreement. As of December 31, 2016, the Company issued 83,280 shares of common stock having a fair value of $36,435 ($0.30 - $0.5/share) based upon the most recent trading price per share of the Company’s common stock (See Note 11). On May 9, 2016, Mr. William Jamieson resigned as a Director in the Company. Mr. Jamieson’s resignation was not the result of any disagreement with us on any matter relating to our operations, policies (including accounting or financial policies) or practices. A majority of the Board of Directors decided to restructure the Board of Directors to better reflect the Company’s current business direction and Mr. Jamieson voluntarily agreed to resign as part of that restructuring effort. Mr. Jamieson was issued 83,280 shares of common stock as part of an agreement with the Company and the Company recorded a fair value of $54,049($0.649/share) based upon the most recent trading price per share of the Company’s common stock.

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Shareholders' Equity	NOTE 15 - SHAREHOLDERS’ EQUITY Convertible Series A Preferred Stock During the third quarter of fiscal 2016, the Company initiated a subscription agreement to offer accredited investors up to 1,000,000 units (“Units”) of securities, each Unit consists of one (1) share of Series A Convertible Preferred Stock and one (1) Series A Warrant (“Warrant”). The price per Unit was $0.50 for a maximum aggregate proceeds of $500,000. There are no dividends on the Series A Convertible Preferred Stock. The Warrants were exercisable at $0.50 per share for a period of one year. As of September 30, 2017, the warrants were not exercised. Therefore, the Company has disclosed the expiration of the Warrants. From August 15 to August 29, 2016, the Company sold an aggregate of 250,000 Units to three (3) investors for total proceeds of $125,000. During the year ended December 31, 2017 and 2016, the Company amortized $33,238 and $0 of debt discount related to the warrants, respectively. The remaining debt discount related to the warrants is $0. On March 20, 2017, the Company’s Series A Preferred Convertible Stock shareholders (“Series A Holders”) each voted to waive and remove the provisions of Section 5(iii) of the Certificate of Designations of the Series A Preferred Stock Designation. Series A Holders have each agreed individually and also as a group to convert their Series A Convertible Preferred Stock into common stock at a conversion price equal to $0.30 per share. A total of 250,000 shares of the Company’s Series A Preferred Convertible Stock were converted into an aggregate of 416,667 shares of common stock. As a result of this action, there currently are no Series A Convertible Preferred Stock issued and outstanding. From April 26, 2017 through May 3, 2017, the Company sold an aggregate of 750,000 shares of Series A Preferred Common Stock to thirteen (13) U.S. accredited investors at $0.40 per share for proceeds of $300,000. Common Stock On January 19, 2016, the Company issued 300,000 shares of common stock to Kodiak Capital Group, LLC as a commitment fee for a Two Million Dollar Equity Financing Agreement. The Company recorded a fair value of $120,000 ($0.40 per share) based upon the most recent trading price per share of the Company’s stock. The Company is subject to a Registration Rights Agreement which requires the Company to file a S1 Registration Statement with the SEC by March 31, 2016 and must receive a notice of effectiveness from the SEC prior to executing a Put Notice. The Purchase Price of the security is based on 80% of the market price based on the Put Date. Market price is calculated on the lowest daily volume weight average price for any trading day during the valuation period, which is the five days from the Put Notice to the Put Date. On January 22, 2016, the Company issued 125,000 shares of common stock to Emerging Growth, LLC, to provide investor and public relations services. The Company recorded a fair value of $43,750 ($0.35 per share) based upon the most recent trading price per share of the Company’s stock. On March 14, 2016, the Company issued 11,330 shares to a consultant for services rendered, of common stock with a fair value of $4,986 ($0.44 per share) based upon the most recent trading price per share of the Company’s stock. On March 22, 2016, the Company entered into a securities purchase agreement with FirstFire Global Opportunities Fund, LLC, and Rockwell Capital Partners Inc., relating to the issuance and sale of notes of $272,500 in aggregate principal amount including $250,000 actual payment of purchase price plus a 9% original issue discount, and an aggregate total of 50,000 shares of common stock valued at $23,500 ($0.47 per share). The notes carry an interest on the unpaid principal amount at the rate of 3% per annum. Any principal amount or interest which is not paid when due shall bear interest at the rate of 15% per annum from the due date until the same is paid. The notes mature on September 22, 2016 and may be prepaid in whole or in part except otherwise explicitly set forth in the Note. If the Company exercises its right to prepay or repay the notes, the Company shall make payment to the note holders of an amount in cash equal to the sum of 125% multiplied by the principal amount plus accrued and unpaid interest on the principal amount to the optional prepayment date plus default interest, if any. The notes convert into shares of common stock at a price equal to $0.30; provided, however that from and after the occurrence of any event of default hereunder, the conversion price shall be the lower of: (i) the fixed conversion price or (ii) 45% multiplied by the lowest sales price of the common stock in a public market during the ten (10) consecutive trading day period immediately preceding the trading day that the Company receives a Notice of Conversion (as defined in the notes). On March 23, 2016, the Company issued 100,000 shares of common stock to one U.S. accredited investor at $0.50 per share for cash totaling $50,000. On March 31, 2016, the Company issued 5,000 shares to a consultant for services rendered, of common stock with a fair value of $2,050 ($0.41 per share) based upon the most recent trading price per share of the Company’s stock. On January 17, 2017, the Company issued 800,000 shares of common stock to Lyons Capital, LLC for a six-month consulting and road show services agreement. The Company recorded fair value of $352,000 ($0.44 per share) based upon the most recent trading price per share of the Company’s stock. From February 22, 2017 through March 15, 2017, the Company sold, in reliance upon Regulation D Rule 506, a total of 2,060,000 shares of common stock to seventeen (17) U.S. accredited investors at $0.40 per share for cash totaling $824,000. On March 20, 2017, the Company’s Series A Preferred Convertible Stock shareholders (“Series A Holders”) each voted to waive and remove the provisions of Section 5(iii) of the Certificate of Designations of the Series A Preferred Stock. Series A Holders have each agreed individually and also as a group to convert their Series A Convertible Preferred Stock into common stock at a conversion price equal to $0.30 per share. A total of 250,000 shares of the Company’s Series A Preferred Convertible Stock were converted into an aggregate of 416,667 shares of common stock. On March 20, 2017, the Company entered into a settlement agreement relating to two (2) promissory notes with FirstFire Global Opportunities Fund, LLC dated October 19, 2016 and December 12, 2016. Pursuant to the settlement, the Company paid the holder an aggregate of $252,917 in cash and issued 333,333 shares of common stock. The Company was released from any further liability under this FirstFire Global Opportunities Fund, LLC note upon payment of this amount. On March 24, 2017, the Company entered into a securities purchase agreement with Tangiers Global, LLC (“Tangiers”) relating to the issuance and sale of notes (“Tangiers Note”) in the aggregate principal amount of up to $550,000, which includes a 10% original issue discount. The Tangiers Note is convertible into shares of common stock at a price equal to $0.30 per share. On October 10, 2017, the Company executed Amendment #1 (“Amendment #1”) to the Tangiers Note for a final draw of $250,000 payment plus a 10% original issue discount (the “Final Draw”). Amendment #1 modified the maturity date of the Tangiers Note from eight months to six months from the effective date of each payment. In addition, Amendment #1 included use of proceeds for the $250,000 received from Tangiers. All other terms and conditions of the Tangiers Note remain effective and were not amended. From April 26, 2017 through May 3, 2017, the Company sold an aggregate of 750,000 shares of Series A Preferred Common Stock to thirteen (13) U.S. accredited investors at $0.40 per share for proceeds of $300,000. On June 1, 2017, the Company issued 250,000 shares of common stock for a 12-month investor relations consulting agreement. The Company recorded fair value of $55,000 ($0.22 per share) based upon the most recent trading price per share of the Company’s stock. On September 6, 2017, the Company issued 758,401 shares of common stock Rick Gutshall, former Interim-Chief Executive Office, former Chief Financial Officer, and Director, related to the merger of the Company and Alamo CBD. The Company recorded fair value of $144,096 ($0.19 per share) based upon the most recent trading price per share of the Company’s stock. On October 12, 2017, the Company issued a promissory note to Tangiers Global, in the principal amount of $50,000 in order to induce Tangiers Global to enter into the Investment Agreement. The note bears interest at a rate of 10% per annum and matures on May 12, 2018. Tangiers Global may, at any time, convert the unpaid principal amount of the note into shares of the Company’s common stock at a conversion price of $0.1666 per share. On October 17, 2017, the Company issued 329,670 shares of its common stock to Tangiers pursuant to Tangiers’ conversion of $30,000 of Note 1 at a conversion price of $0.09. On December 18, 2017, the Company issued 516,648 shares of its common stock to Tangiers pursuant to Tangiers’ conversion of $45,000 of Note 1 at a conversion price of $0.09. Common Stock Warrants On September 26, 2016, the Company issued the Rifici Note to Chuck Rifici Holdings, Inc., relating to the issuance of $225,500 in aggregate principal including a $204,000 actual payment of purchase price plus a 10% original issue discount. In conjunction with the issuance of the Rifici Note, the Company issued a one-year warrant to purchase 250,000 shares of common stock at an exercise price of $0.30 per share. The warrant expired September 26, 2017 and was not exercised. Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2016 500,000 $ 0.40 — Granted — — — Exercised — — — Canceled/Forfeited 250,000 0.50 — Expired 250,000 0.30 Balance December 31, 2017 — $ — There were no warrants outstanding as of December 31, 2017. Common Stock Equivalents For the year ended December 31, 2016, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.30 - 0.50 500,000 0.69 32,500 Lattice Binomial model was used to value aggregate intrinsic value. The Company has the following common stock equivalents for the years ended December 31, 2017 and 2016, respectively: 2017 2016 Convertible debt (exercise price - $0.30/share) 3,580,375 916,667 Series A convertible preferred shares (exercise price - $0.08/share) — 1,633,987 3,580,375 2,550,654

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 16 - INCOME TAXES Indoor Harvest operates in the United States; accordingly, federal and state income taxes have been provided based upon the tax laws and rates of the US. Deferred taxes are determined based on the temporary differences between the financial statement and income tax bases of assets and liabilities as measured by the enacted tax rates, which will be in effect when these differences reverse. The components of deferred income tax assets and liabilities as of December 31, 2017 and 2016 are as follows: Description 2017 2016 Deferred tax assets Net operating losses $ 1,118,472 $ 1,005,468 Deferred tax liabilities Accelerated tax depreciation 19,183 19,183 Net deferred tax assets 1,137,655 986,285 Less: Valuation allowance (1,137,655 ) (986,285 ) Net $ — $ — At December 31, 2017 and 2016, the Company has provided a full valuation allowance for the deferred tax assets. The Company’s accumulated net operating loss as of December 31, 2017 of $5,856,768, if not used, will begin to expire in 2037. The change in the valuation allowance for the year ended December 31, 2017 amounted to $151,370, $8,000 of which was attributable to the change in tax rates resulting form 2017 tax legislation. The Company experienced a change in control for tax purposes in 2017 as a result of the merger with Alamo CBD. Accordingly, the future utilization of net operating losses will be severely restricted by Section 382 of the Internal Revenue Code. Management is in the process of assessing this impact. This loss carryforward expires according to the following schedule: Year Ending December 31, Amount 2033 $ 217,074 2034 368,378 2035 761,615 2036 1,610,192 2037 2,899,509 $ 5,856,768

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	NOTE 17 - SUBSEQUENT EVENTS On January 9, 2018, the Company issued 899,685 shares of its common stock to Tangiers pursuant to Tangiers’ conversion of $100,000 of Note 1 at a conversion price of $0.11. On January 15, 2018 Ms. Sandra Fowler, was appointed as the Chief Marketing Officer of the Company. Pursuant to the terms of the Fowler Employment Agreement, Ms. Fowler shall serve as Chief Marketing Officer of the Company. The initial term of the agreement will expire on January 15, 2019 and commencing on January 15, 2019 and on each anniversary of such date thereafter, the term of the Fowler Employment Agreement shall automatically renew for a one-year period, unless earlier terminated by either party pursuant to the terms of the Fowler Employment Agreement. In consideration for Ms. Fowler’s services, under the Fowler Employment Agreement, Ms. Fowler shall receive (i) an annual base salary of $48,000 and (ii) 200,000 shares of restricted common stock of the Company. Further, pursuant to the Fowler Employment Agreement, the Company agreed to revise the annual base compensation for Ms. Fowler to $65,000, after 90 days of the execution of the Fowler Employment Agreement, or after the Company raises not less than $1,000,000 from sales of its equity securities subsequent to the execution of the Fowler Employment Agreement, whichever may come first. In addition, Ms. Fowler shall be eligible to participate in any equity-based incentive compensation plan or programs adopted by the Company’s board of directors. On January 16, 2018, the Company issued and sold an 8% Fixed Convertible Promissory Note (“Note 3”) to Tangiers (the “Buyer”), in the aggregate principal amount of up to $550,000, which includes a 10% original issue discount. Note 3 is convertible into shares of the Company’s common stock at a conversion price of $0.30 per share. However, if Note is not paid back on or before the maturity date, defined in Note 3 as a “Maturity Default”, the conversion price of Note 3 shall then be adjusted to be equal to the lower of: (i) $0.30 or (ii) 65% multiplied by the lowest trading price of the Company’s common stock in the fifteen (15) consecutive trading day period immediately preceding the trading day that the Company receives a notice of conversion of Note 3. As of April 17, 2018, the balance under Note 3 is $231,660, which includes $17,160 guaranteed interest. As of April 17, 2018, Note 3 can be converted into 650,000 shares of the Company’s common stock. Note 3 has a maturity date of July 16, 2018. On February 5, 2018, Dr. Coleman and Benjamin Coleman voluntarily returned and canceled an aggregate of 3,280,470 common shares in order to prevent dilution to the shareholders during the Company’s efforts to secure new senior management, provide additional incentive equity and to form an advisory board. The return of common stock by Dr. Coleman and Benjamin Coleman was a non-cash transaction and reduces the common stock outstanding as of April 17, 2018. On February 20, 2018, Mr. Daniel Weadock was appointed Chief Executive Officer and Director of the Company. On February 20, 2018, the Company entered into an executive employment agreement with Mr. Weadock (the “Weadock Employment Agreement”), pursuant to which Mr. Weadock agreed to act as the Company’s chief executive officer. Pursuant to the terms of the Weadock Employment Agreement, Mr. Weadock initial will not receive a salary. However, effective on the business day after the date on which the Company achieves Capitalization (as hereinafter defined) of $2,000,000 or more, Mr. Weadock’s annual base salary will be $100,000. For purposes of the Weadock Employment Agreement, “Capitalization” means aggregate net cash proceeds received by the Company from (a) the Company’s sale of common stock pursuant to Puts (as such term is defined in the Investment Agreement dated as of October 12, 2017 by and between the Company and Tangiers Global, LLC (the “Investment Agreement”)) under the Investment Agreement, and/or (b) any other sale by the Company of common stock or preferred stock, whether in a public offering or a private placement. In addition, pursuant to the terms of the Weadock Employment Agreement, the Company agreed to grant Mr. Weadock (i) 300,000 shares of restricted stock as soon as administratively practicable following execution of the Weadock Employment Agreement, and (ii) 1,584,202 shares of restricted common stock, consistent with the grant and vesting schedule set forth in the agreement; provided, however, that no grant will be made and no shares will be issued with respect to any grant if Mr. Weadock is not employed by the Company as an executive on the respective Date of Grant as set forth in the agreement. The Weadock Employment Agreement has a term of one year, unless Mr. Weadock’s employment is terminated sooner by the board of directors, and the term will be extended for additional one-year periods unless the Company or Mr. Weadock gives the other party at least 30 days’ prior written notice of its intent not to renew. On February 20, 2018, the Company also entered into a compensation agreement with Mr. Weadock (the “Director Compensation Agreement”).Pursuant to the terms of the Director Compensation Agreement, the Company agreed to grant Mr. Weadock an aggregate of 240,000 shares of restricted common stock, consistent with the grant and vesting schedule set forth in the agreement; provided, however, that no grant will be made and no shares will be issued with respect to any grant, if Mr. Weadock is not a member of the Company’s board of directors on the respective Date of Grant as set forth in the agreement. If the Company is acquired by, or merged into and with, another entity prior to the last Date of Vesting set forth in the agreement (i.e. February 23, 2022), all shares issuable to Mr. Weadock under the Director Compensation Agreement will become fully vested and non-forfeitable. The Company also agreed to reimburse Mr. Weadock for all reasonable travel and incidental expenses incurred by Mr. Weadock in performing his services and attending meetings as approved in advance by the Company. Also, on February 20, 2018, the Company also entered into an indemnity agreement with Mr. Weadock (the “Weadock Indemnity Agreement”). Pursuant to the terms of the Indemnity Agreement, the Company agreed to use reasonable efforts to obtain and maintain in full force and effect directors’ and officers’ liability insurance (“D&O Insurance”) in reasonable amounts from established and reputable insurers; provided, however, the Company shall have no obligation to obtain or maintain D&O Insurance if the Company determines in good faith that such insurance is not reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage provided, the coverage is reduced by exclusions so as to provide an insufficient benefit, or Mr. Weadock is covered by similar insurance maintained by a subsidiary of the Company. In addition the foregoing, the Company will indemnify Mr. Weadock from certain third party actions, derivative actions and actions where Mr. Weadock is decreased; provided, however, the Company shall not be obligated to indemnify Mr. Weadock for actions including, but not limited to, actions initiated by Mr. Weadock, for any action in which it is determined that the material assertions made by Mr. Weadock in such proceeding were not made in good faith or were frivolous, for any settlements not authorized by the Company, for any actions on the account of Mr. Weadock’s willful misconduct, and for any expenses and the payment of profits arising from the purchase and sale Mr. Weadock of securities in violation of Section 16(b) of the Securities Exchange Act, or any similar successor statute; provided, further that, that the Company shall not be obligated to indemnify Mr. Weadock for expenses or liabilities of any type whatsoever which have been paid directly to Mr. Weadock pursuant to the Company’s D&O Insurance policy. On March 5, 2018, the Company issued 269,716 shares of its common stock to Tangiers pursuant to Tangier’s conversion of $25,000 of Note 1 at a conversion price of $.09. On March 21, 2018, the Company issued 295,631 shares of its common stock to Tangiers pursuant to Tangier’s conversion of $25,000 of Note 1 at a conversion price of $.08. On April 13, 2018, the Company issued 769,231 shares of its common stock to Tangiers pursuant to Tangier’s conversion of $50,000 of Note 1 at a conversion price of $.07.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Restated) (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Nature of Operations and Organization	Nature of Operations and Organization Indoor Harvest Corp. (the “Company,”) is a Texas corporation formed on November 23, 2011. Our principal executive office is located at 5300 East Freeway Suite A, Houston, Texas 77020. On August 3, 2017, we formed Alamo Acquisition, LLC, a wholly owned Texas limited liability company (“Alamo Acquisition Sub”). On August 4, 2017, we consummated a reverse triangular merger pursuant to which Alamo Acquisition Sub acquired all of the outstanding member interests of Alamo CBD, LLC. (“Alamo CBD”), a Texas limited Liability Company. Upon closing of the Alamo Merger, the member interests (“Alamo Survivor Members”) of Alamo CBD were exchanged for 7,584,008 shares of Indoor Harvest’s common stock, the parent company of Alamo Acquisition Sub, and Alamo CBD continued as our surviving wholly-owned subsidiary, and Alamo Acquisition Sub ceased to exist. On October 17, 2018, the Board of Directors (the “Board”) of the Company was notified by the Company’s independent registered public accounting firm, Thayer O’Neal Company, LLC (“Thayer”) that, in July 2018, information came to its attention that led it to investigate whether the Company’s acquisition of Alamo CBD was wrongly accounted for as a business combination. Thayer concluded this investigation on October 17, 2018 and notified the Board that the Company, pursuant to generally accepted accounting principles, should have accounted for the Alamo CBD transaction as an asset acquisition. From inception until August 4, 2017, the Company provided full service, state of the art design-build, engineering, procurement and construction services to the indoor and vertical farming industry. The Company provided production platforms, mechanical systems and complete custom designed build outs for both Controlled Environment Agriculture (“CEA”) and Building Integrated Agriculture (“BIA”), for two unique industries, produce and cannabis. In mid-2016, the Company began efforts to separate its produce and cannabis related operations due to ongoing feedback from both clients and potential institutional investors. It was determined that the Company’s involvement in the cannabis industry was creating conflicts for clients and potential institutional investors wishing to work with the Company from the produce industry due to the public perception and political issues surrounding the cannabis industry. By late-2016, the Company had decided to cease actively selling its products and services to the vertical farming industry and to focus on utilizing the Company’s developed technology and methods for the cannabis industry. On August 4, 2017, the Company ceased actively supporting business development of vertical farms for produce production.
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“GAAP”). It is management’s opinion, however, that all material adjustments (consisting of normal and recurring adjustments) have been made which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, the estimate of percentage of completion on construction contracts in progress at each reporting period which we rely on as a primary basis of revenue recognition, estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Indoor Harvest Corp. and its wholly-owned subsidiary, Alamo CBD. All significant inter-company accounts and transactions have been eliminated in consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid instruments with a maturity of three months or less to be cash and cash equivalents.
Accounts Receivable and Work in Progress	Accounts Receivable and Work in Progress Work in progress consists of costs recorded and revenue earned on projects recognized on the percentage of completion method for work performed on contracts in progress at September 30, 2017, and December 31, 2016. The Company records revenue based on contractual agreements entered into at the inception of construction contracts. Amounts are payable from customers based on milestones established in each contract. Amounts are billed at milestone completion and are reflected as accounts receivable when billed. Costs and estimated earnings are accumulated on projects in process and compared to amounts billed based on the percentage of completion method of accounting (cost to cost). Costs incurred in excess of amounts billed and related profit recognized are reflected as an asset on the balance sheet as costs and estimated earnings in excess of billings. Unearned billings are reflected in the balance sheet as a liability as billings in excess of costs and estimated earnings on projects in process (See Note 9).
Inventories	Inventories Inventory consists primarily of raw materials and packaging materials and is valued at the lower of cost or market. Cost is determined using the weighted average method and the average cost is recomputed after each inventory purchase or sale. Inventory is periodically reviewed to identify obsolete or damaged inventory and impaired values. Inventory is comprised of raw materials such as steel for our framing systems and packaging materials such as boxes and pallets.
Revenue Recognition	Revenue Recognition The Company recognizes revenue on arrangements in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No. 605, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company will generate revenue from the design and installation of the equipment and licensing of technology. Revenue from construction contracts are reported under the percentage of completion method for financial statement purposes. The estimated revenue for each contract reflected in the financial statements represent that percentage of estimated total revenue that costs incurred to date bear to estimated total costs, based on the Company’s current estimates. With respect to contracts that extend over one or more accounting periods, revisions in costs and revenue estimates during the work are reflected in the period the revisions become known. When current estimates of total contract costs indicate a loss, provision is made for the entire estimated loss. The asset, “costs and estimated earnings in excess of billings on uncompleted contracts,” represents revenues recognized in excess of amounts billed. The liability, “Estimated earnings on uncompleted contracts,” represents billings in excess of revenues recognized. Billing practices for these projects are governed by the contract terms of each project based upon actual costs incurred, achievement of milestones, or pre-agreed schedules. Billings do not necessarily correlate with revenue recognized under the percentage of completion method of accounting. Except for claims and change orders that are in the process of being negotiated with customers, unbilled work is usually billed during normal billing processes following achievement of the contractual requirements.
Stock Based Compensation	Stock Based Compensation The Company recognizes stock-based compensation in accordance with ASC 718-10, Stock Compensation. ASC 718-10 focuses on transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus in which an entity obtains employee services in stock-based payment transactions. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award (with limited exceptions).
Loss Per Share	Loss per Share Basic earnings per share amounts are calculated based on the weighted average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the weighted average numbers of shares of common stock outstanding for the periods, including dilutive effects of stock options, warrants granted and convertible preferred stock. Dilutive options and warrants that are issued during a period or that expire or are canceled during a period are reflected in the computations for the time they were outstanding during the periods being reported. Since Indoor Harvest has incurred losses for all periods, the impact of the common stock equivalents would be anti- dilutive and therefore are not included in the calculation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments We adopted accounting guidance for financial and non-financial assets and liabilities (ASC 820). The adoption did not have a material impact on our results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share- based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: ● Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. ● Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. ● Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
Income Taxes	Income Taxes The Company accounts for income taxes pursuant to FASB ASC 740—Income Taxes, which requires recognition of deferred income tax liabilities and assets for the expected future tax consequences of events that have been recognized in the financial statements or tax returns. The Company provides for deferred taxes on temporary differences between the financial statements and tax basis of assets using the enacted tax rates that are expected to apply to taxable income when the temporary differences are expected to reverse. ASB ASC 740 establishes a more-likely-than-not threshold for recognizing the benefits of tax return positions in the financial statements. Also, the statement implements a process for measuring those tax positions that meet the recognition threshold of being ultimately sustained upon examination by the taxing authorities. There are no uncertain tax positions taken by the Company on its tax returns. The Company files tax returns in the U.S. and states in which it has operations and is subject to taxation. Tax years subsequent to 2008 remain open to examination by U.S. federal and state tax jurisdictions. Tax years 2017, 2016, 2015, 2014, and 2013, remain subject to examination by the IRS and respective states. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Reform Act”). We recognize the impact of tax legislation in the period in which the law is enacted. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the effect of the changes in the Tax Reform Act. Consistent with that guidance, we recognized provisional amounts based upon our interpretation of the tax laws and estimates which require significant judgments. The actual impact of these tax laws may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in our interpretations and assumptions, additional guidance that may be issued by the government and actions we may take as a result of these enacted tax laws. Any adjustments recorded to the provisional amounts will be included in income from operations as an adjustment to tax expense.
Property and Equipment	Property and Equipment Property and equipment is recorded at cost and depreciated or amortized using the straight-line method over the estimated useful life of the asset or the underlying lease term for leasehold improvements, whichever is shorter. The estimated useful life by asset description is noted in the following table: Asset description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * * The shorter of 5 years or the life of the lease. Additions are capitalized and maintenance and repairs are charged to expense as incurred. Gains and losses on dispositions of equipment are reflected in other income.
Goodwill	Goodwill In accordance with ASC 350 Goodwill is not amortized but evaluated for impairment annually or more often if indicators of a potential impairment are present.
Intangible Assets (Restated)	Intangible Assets (Restated) In accordance with ASC 350 Goodwill and Other Intangible Assets, indefinite-lived intangible assets are not amortized but are evaluated for impairment annually or more often if indicators of a potential impairment are present. Indefinite-lived intangible assets consist of the Company’s domain name. Finite-lived intangible assets include software and is amortized over a 3 to 5-year period. The Company recognized $1,440,961 and $0 for impairment charges taken during the year ended December 31, 2017 and 2016, respectively.
Patent and Patent Application Expenses	Patent and Patent Application Expenses Although the Company believes that its patent and underlying technology will have continuing value, the amount of future benefits to be derived from the patent is uncertain. Therefore, patent costs are expensed as incurred.
Research and Development	Research and Development Research and development expenditures are charged to expense as incurred.
Advertising Expense	Advertising Expense Advertising and promotional costs are expensed as incurred.
Reclassifications	Reclassifications Certain expense items have been reclassified in the statement of operations for the year ended December 31, 2016, to conform to the reporting format adopted for the year ended December 31, 2017.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect as of the date of the issuance of these financial statements. The following pronouncements may significantly impact future reporting of financial position and results of operations. Management is currently assessing implementation. The FASB has issued Accounting Standards Update (ASU) No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business, clarifying the definition of a business. The amendments affect all companies and other reporting organizations that must determine whether they have acquired or sold a business. For public companies, the amendments are effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The FASB has issued its new lease accounting guidance in Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: ● A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and ● A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ● Under the new guidance, lessor accounting is largely unchanged. Certain targeted improvements were made to align, where necessary, lessor accounting with the lessee accounting model and Topic 606, Revenue from Contracts with Customers. ● The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. Public business entities should apply the amendments in ASU 2016-02 for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (i.e., January 1, 2019, for a calendar year entity). The FASB has issued Accounting Standards Update (ASU) No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The amendments are intended to improve the accounting for employee share-based payments and affect all organizations that issue share-based payment awards to their employees. Several aspects of the accounting for share-based payment award transactions are simplified, including: (a) income tax consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. For public companies, the amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For private companies, the amendments are effective for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. Early adoption is permitted for any organization in any interim or annual period. The FASB has issued Accounting Standards Update No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. The amendments clarify the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendments do not change the core principle of the guidance in Topic 606. The effective date and transition requirements for the amendments are the same as the effective date and transition requirements in Topic 606. Public entities should apply the amendments for annual reporting periods beginning after December 15, 2017, including interim reporting periods therein (i.e., January 1, 2018, for a calendar year entity). Early application for public entities is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The effective date for nonpublic entities is deferred by one year.
Derivative Liability	Derivative Liability The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedge relationships and the types of relationships designated are based on the exposures hedged. At December 31, 2017 and December 31, 2016, the Company did not have any derivative instruments that were designated as hedges.
Beneficial Conversion Feature	Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument. The discount is amortized to interest expense over the life of the debt.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Restated) (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Estimated Useful Life by Asset Description	The estimated useful life by asset description is noted in the following table: Asset description Estimated Useful Life (Years) Furniture and equipment 3 - 5 Tooling equipment 10 Leasehold improvements * * The shorter of 5 years or the life of the lease.

Restatement of Financial Stat_2

Restatement of Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Changes and Error Corrections [Abstract]
Schedule of Restatement of Operations	The effects of the adjustments on the Company’s previously issued financial statements as at December 31, 2017 and for the year ended December 31, 2017 are summarized as follows: Originally Restatement Statements of Operations Reported Adjustment As Restated For the twelve months ended December 31, 2017 Impairment loss from Goodwill $ 1,440,961 $ (1,440,961 ) $ - Impairment loss of intangible assets $ - $ 1,440,961 $ 1,440,961 Total operating expenses $ 1,440,961 $ - $ 1,440,961

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consist of the following at December 31, 2017 and 2016: Classification 2017 2016 Furniture and equipment $ 11,666 $ 123,829 Tooling equipment — 27,015 Leasehold improvements 38,717 57,780 Computer equipment 3,019 8,933 Research and development lab — 59,482 Total 53,402 277,039 Less: Accumulated depreciation (28,779 ) (118,621 ) Property and equipment, net $ 24,623 $ 158,418

Commitments & Contingencies (Ta

Commitments & Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Rent Expense	Rent expense for the years ended December 31, 2017 and 2016, were: 2017 2016 Rent expense $ 52,550 $ 51,403
Schedule of Rental Commitments	At December 31, 2017, rental commitments are as follows: Years Ending December 31, Amount 2018 $ 55,560 2019 18,876 Total $ 74,436

Loan Payable (Tables)

Loan Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Maturities of Loan Payable	Year Ending December 31, Amount 2018 $ 7,520 2019 8,328 2020 4,495 $ 20,343

Concentrations (Tables)

Concentrations (Tables)	12 Months Ended
	Dec. 31, 2017
Risks and Uncertainties [Abstract]
Schedule of Concentration of Accounts Receivable and Sales	At December 31, 2017 and December 31, 2016, the Company had concentrations of accounts receivable of: Customer December 31, 2017 December 31, 2016 Tweed, Inc. 0 % 100 % For the years ended December 31, 2017 and December 31, 2016, the Company had a concentration of sales of: 2017 2016 Customer Revenue ($) Percentage Revenue ($) Percentage Tweed (Canopy Growth Corporation) $ — — % $ 80,620 50 % ER Michigan (Michigan State University) $ — — % $ 28,385 18 % Urbanika Farms $ — — % $ 27,600 17 % University of Arizona CEAC $ — — % $ 18,626 11 % GSS Colorado $ — — % $ 5,000 2 % PH Research Platform $ — — % $ 3,765 2 % Total $ — — % $ 163,996 100 %

Intangible Assets (Restated) (T

Intangible Assets (Restated) (Tables)	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following at December 31, 2017 and December 31, 2016: Classification 2017 2016 Domain name $ 2,000 $ 2,000 Facilities Manager’s Package Online 1,022 1,022 MLC CD Systems (software) 7,560 7,560 Total 10,582 10,582 Less: Accumulated amortization (4,690 ) (2,978 ) Intangible assets, net $ 5,892 $ 7,604

Work in Process (Tables)

Work in Process (Tables)	12 Months Ended
	Dec. 31, 2017
Contractors [Abstract]
Schedule of Work in Progress	Work in progress as of December 31, 2017 and December 31, 2016, consisted of the following: Description 2017 2016 Costs incurred on uncompleted contracts $ — $ 80,620 Estimated earnings — — Less: Billings to date — (100,775 ) Total — (20,155 ) Reflected in balance sheet as: Costs and estimated earnings in excess of billings on contracts in process $ — $ — Billings in excess of costs and estimated earnings on contracts in process — 20,155 Total $ — $ 20,155

Debt and Convertible Loan Pay_2

Debt and Convertible Loan Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Debt Discount and Original Issuance Costs	2017 2016 Debt discount, beginning of period $ 152,617 $ — Additional debt discount and debt issue cost 383,786 417,834 Amortization of debt discount and debt issue cost (466,862 ) (265,217 ) Debt discount, end of period $ 69,541 $ 152,617
Schedule of Debt Issue Costs	The following is a summary of the Company’s debt issue costs for the years ended December 31, 2017 and 2016: 2017 2016 Debt discount, beginning of period $ — $ — Additional debt discount — 20,000 Amortization of debt discount — (20,000 ) Debt discount, end of period $ — $ —

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Change in Fair Value of the Derivative Liabilities	The following schedule shows the change in fair value of the derivative liabilities at year end December 31, 2017: Derivative liabilities - December 31, 2016 $ — Add fair value at the commitment date for convertible notes issued during the current year 213,453 Less derivatives due to conversion (101,493 ) Fair value mark to market adjustment for derivatives 442,957 Derivative liabilities - December 31, 2017 554,917 Less : current portion (554,917 ) Long-term derivative liabilities $ — The following schedule shows the change in fair value of the derivative liabilities at year end December 31, 2016: Derivative liabilities - December 31, 2015 $ — Add fair value at the commitment date for convertible notes issued during the current year 270,331 Less derivatives due to conversion (412,086 ) Fair value mark to market adjustment for derivatives 141,755 Derivative liabilities - December 31, 2017 — Less : current portion — Long-term derivative liabilities $ —
Schedule of Derivative Liabilities Based Upon Management Assumptions	The fair value at the commitment and re-measurement dates for the Company’s derivative liabilities were based upon the following management assumptions during the current quarter: Assumption Commitment Date Remeasurement Date Expected dividends: — % — % Expected volatility: 134 % 130 - 169 % Expected term (years): 0.42 0.15 - 0.36 years Risk free interest rate: 1.19 % 1.25 - 1.39 %

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Schedule of Warrant Activity	Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in Years) Balance, December 31, 2016 500,000 $ 0.40 — Granted — — — Exercised — — — Canceled/Forfeited 250,000 0.50 — Expired 250,000 0.30 Balance December 31, 2017 — $ —
Schedule of Outstanding Warrants	For the year ended December 31, 2016, the following warrants were outstanding: Exercise Price Warrants Outstanding Warrants Exercisable Weighted Average Remaining Contractual Life Aggregate Intrinsic Value $ 0.30 - 0.50 500,000 0.69 32,500
Schedule of Common Stock Equivalents	The Company has the following common stock equivalents for the years ended December 31, 2017 and 2016, respectively: 2017 2016 Convertible debt (exercise price - $0.30/share) 3,580,375 916,667 Series A convertible preferred shares (exercise price - $0.08/share) — 1,633,987 3,580,375 2,550,654

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Deferred Income Tax Assets and Liabilities	The components of deferred income tax assets and liabilities as of December 31, 2017 and 2016 are as follows: Description 2017 2016 Deferred tax assets Net operating losses $ 1,118,472 $ 1,005,468 Deferred tax liabilities Accelerated tax depreciation 19,183 19,183 Net deferred tax assets 1,137,655 986,285 Less: Valuation allowance (1,137,655 ) (986,285 ) Net $ — $ —
Schedule of Operating Loss Carry Forward	This loss carryforward expires according to the following schedule: Year Ending December 31, Amount 2033 $ 217,074 2034 368,378 2035 761,615 2036 1,610,192 2037 2,899,509 $ 5,856,768

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Restated) (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Number of common stock exchanged shares	7,584,008
Impairment charges	$ 1,440,961	$ 0
Minimum [Member]
Finite-lived intangible assets	3 years
Maximum [Member]
Finite-lived intangible assets	5 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Restated) - Schedule of Estimated Useful Life by Asset Description (Details)	12 Months Ended
	Dec. 31, 2017
Furniture and Equipment [Member]
Estimated Useful Life (Years)	3 - 5 Years
Tooling Equipment [Member]
Estimated Useful Life (Years)	10 Years
Leasehold Improvements [Member]
Estimated Useful Life (Years)	The shorter of 5 years or the life of the lease.

Restatement of Financial Stat_3

Restatement of Financial Statements (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)shares
Number of shares issued for acquisition, value	$ 1,440,961
Alamo CBD [Member]
Goodwill	$ 1,440,961
Number of shares issued for acquisition | shares	7,584,008
Number of shares issued for acquisition, value	$ 1,440,961

Restatement of Financial Stat_4

Restatement of Financial Statements - Schedule of Restatement of Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Impairment loss from Goodwill
Impairment loss of intangible assets	1,440,961	$ 0
Total operating expenses	1,440,961
Originally Reported [Member]
Impairment loss from Goodwill	1,440,961
Impairment loss of intangible assets
Total operating expenses	1,440,961
Restatement Adjustment [Member]
Impairment loss from Goodwill	(1,440,961)
Impairment loss of intangible assets	1,440,961
Total operating expenses

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 4,412,050	$ 2,075,000
Net cash used in operations	1,019,729	662,170
Accumulated deficit	$ 8,408,822	$ 3,996,772

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 51,507	$ 51,484
Sale of equipment	23,467	46,626
Equipment in exchange	10,800	10,000
Write off of assets	201,651
Loss on sale of equipment	$ 73,750	36,627
Other assets used for services		$ 2,157

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Total	$ 53,402	$ 277,039
Less: Accumulated Depreciation and Amortization	(28,779)	(118,621)
Property and Equipment, net	24,623	158,418
Furniture and Equipment [Member]
Total	11,666	123,829
Tooling Equipment [Member]
Total		27,015
Leasehold Improvements [Member]
Total	38,717	57,780
Computer Equipment [Member]
Total	3,019	8,933
Research and Development Lab [Member]
Total		$ 59,482

Commitments & Contingencies (De

Commitments & Contingencies (Details Narrative)	Feb. 20, 2014USD ($)ft²	Dec. 31, 2017USD ($)
Commitments and Contingencies Disclosure [Abstract]
Lease agreement period	60 months
Area of land | ft²	10,000
Payments for deposit	$ 12,600
Monthly rent payable	$ 4,200
Monthly base rent percentage	6.00%
Period of increasing base rent	2 years
Deferred rent payable		$ 6,239

Commitments & Contingencies - S

Commitments & Contingencies - Schedule of Rent Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 52,550	$ 51,403

Commitments & Contingencies -_2

Commitments & Contingencies - Schedule of Rental Commitments (Details)	Dec. 31, 2017USD ($)
Commitments and Contingencies Disclosure [Abstract]
2,018	$ 55,560
2,019	18,876
Total	$ 74,436

Asset Acquisition (Restated) (D

Asset Acquisition (Restated) (Details Narrative) - USD ($)	Sep. 06, 2017	Aug. 08, 2017	Aug. 07, 2017	Aug. 04, 2017	Mar. 30, 2017	Mar. 23, 2017	Mar. 15, 2017	Dec. 31, 2017	Dec. 31, 2016
Common stock, par value								$ 0.001	$ 0.001
Common shares issued for cash							2,060,000	824,000
Shares issued price per share							$ 0.40
Impairment loss of intangible assets								$ 1,440,961	$ 0
Initial down payment under the joint venture agreement					$ 250,000
Impairment of goodwill								$ 1,440,961
Vyripharm Enterprises, LLC [Member]
Initial down payment under the joint venture agreement			$ 250,000
Contractual Joint Venture Agreement [Member]
Joint venture investment						$ 5,000,000
Contractual Joint Venture Agreement [Member] | Vyripharm Enterprises, LLC [Member]
Joint venture initial term						5 years
Description of joint venture investment						The Company agreed to contribute a total of $5,000,000 on the basis of $1,000,000 per year for each of the first five (5) years of the Initial Term.
Chad Sykes [Member]
Common stock returned by Chief Cultivation Officer in anticipation of merger (in shares)		2,500,000
Alamo CBD, LLC [Member]
Number of shares exchanged				7,584,008
Additional contribution to members by newly-issued shares of common stock				$ 8,500,000
Common stock, par value				$ 0.001
Additional cash payment by newly-issued shares of common stock				$ 2,500,000
Common shares issued for cash	7,584,008
Fair value of goodwill	$ 1,440,961
Shares issued price per share	$ 0.19

Loan Payable (Details Narrative

Loan Payable (Details Narrative) - USD ($)	Jun. 05, 2015	Dec. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Loan payable term	5 years
Principal loan amount	$ 36,100
Loan payable, interest rate	10.25%
Repayment of principal amount		$ 6,789
Remaining balance		20,343
Note payable - current portion		$ 7,520	$ 6,790

Loan Payable - Schedule of Matu

Loan Payable - Schedule of Maturities of Loan Payable (Details)	Dec. 31, 2017USD ($)
Debt Disclosure [Abstract]
2,018	$ 7,520
2,019	8,328
2,020	4,495
Loan Payable, total	$ 20,343

Concentrations (Details Narrati

Concentrations (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Illumitex, LLC [Member]
Purchasing concentration amount	$ 3,897
Percentage of concentration	74.00%
3rd Coast Pump & Equipment, LLC [Member]
Purchasing concentration amount		$ 29,500
Percentage of concentration		37.00%

Concentrations - Schedule of Co

Concentrations - Schedule of Concentration of Accounts Receivable and Sales (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues		$ 163,996
Accounts Receivable [Member] | Tweed [Member]
Percentage of concentration	0.00%	100.00%
Sales Revenue, Net [Member]
Percentage of concentration	0.00%	2.00%
Revenues		$ 163,996
Sales Revenue, Net [Member] | Tweed [Member]
Percentage of concentration	0.00%	50.00%
Revenues		$ 80,620
Sales Revenue, Net [Member] | ER Michigan [Member]
Percentage of concentration	0.00%	18.00%
Revenues		$ 28,385
Sales Revenue, Net [Member] | Urbanika Farms [Member]
Percentage of concentration	0.00%	17.00%
Revenues		$ 27,600
Sales Revenue, Net [Member] | University of Arizona CEAC [Member]
Percentage of concentration	0.00%	11.00%
Revenues		$ 18,626
Sales Revenue, Net [Member] | GSS Colorado [Member]
Percentage of concentration	0.00%	2.00%
Revenues		$ 5,000
Sales Revenue, Net [Member] | PH Research Platform [Member]
Percentage of concentration	0.00%	2.00%
Revenues		$ 3,765

Intangible Assets (Restated) (D

Intangible Assets (Restated) (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2017	Dec. 31, 2016
Impairment charges
Alamo CBD [Member]
Impairment charges	$ 1,440,961	$ 0

Intangible Assets (Restated) -

Intangible Assets (Restated) - Schedule of Intangible Assets (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Total	$ 10,582	$ 10,582
Less: Accumulated amortization	(4,690)	(2,978)
Intangible assets, net	5,892	7,604
Domain Name [Member]
Total	2,000	2,000
Facilities Manager's Package Online [Member]
Total	1,022	1,022
MLC CD Systems (Software) [Member]
Total	$ 7,560	$ 7,560

Work in Process - Schedule of W

Work in Process - Schedule of Work in Progress (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Contractors [Abstract]
Costs incurred on uncompleted contracts		$ 80,620
Estimated earnings
Less: Billings to date		(100,775)
Total		(20,155)
Costs and estimated earnings in excess of billings on contracts in process
Billings in excess of costs and estimated earnings on contracts in process		20,155
Total		$ 20,155

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Note payable, net of discount		$ 209,786
Convertible note payable, net of debt discount	668,912	122,383
Level 3 in Fair Value Hierarchy [Member]
Derivative liability fair value classified as Level 3	$ 554,916	$ 0

Debt and Convertible Loan Pay_3

Debt and Convertible Loan Payable (Details Narrative)	Dec. 18, 2017USD ($)$ / sharesshares	Oct. 12, 2017USD ($)Investors$ / sharesshares	Oct. 10, 2017USD ($)Investors	Mar. 24, 2017USD ($)Investors$ / shares	Mar. 20, 2017USD ($)$ / sharesshares	Sep. 26, 2016USD ($)	Oct. 17, 2017USD ($)$ / sharesshares	Mar. 20, 2017USD ($)$ / shares	Mar. 15, 2017shares	Oct. 17, 2018USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)	Jun. 05, 2015USD ($)
Debt And Convertible Loan Payable [Line Items]
Repayments of note payable											$ 6,787
Conversion of debt, fair value of shares issued											$ 75,000
Number of shares issued | shares									2,060,000		824,000
Debt face amount													$ 36,100
Accrued interest											$ 49,000	10,334
Additional debt discount												20,000
Amortization of debt issue costs												20,000
Tangiers Note [Member]
Debt And Convertible Loan Payable [Line Items]
Conversion of debt, shares issued | shares							329,670
Conversion of debt, price per share | $ / shares				$ 0.30
Interest rate percentage on unpaid principal amount				8.00%
Conversion rate				65.00%
Number of trading days for conversion | Investors				15
Original debt converted							$ 30,000
Debt Discount And Original Issuance Costs [Member]
Debt And Convertible Loan Payable [Line Items]
Additional debt discount											383,786	417,834
Interest expense											$ 466,862	$ 265,217
Chuck Rifici Holdings Inc [Member]
Debt And Convertible Loan Payable [Line Items]
Repayments of note payable								$ 269,498
Original issue discount percentage						10.00%
Debt face amount						$ 225,500
Firstfire Global Opportunities Fund, LLC [Member] | Securities Purchase Agreement [Member]
Debt And Convertible Loan Payable [Line Items]
Repayments of note payable					$ 252,917
Conversion of debt, fair value of shares issued					$ 100,000
Conversion of debt, shares issued | shares					333,333
Conversion of debt, price per share | $ / shares					$ 0.30			$ 0.30
Tangiers Global, LLC [Member]
Debt And Convertible Loan Payable [Line Items]
Conversion of debt, fair value of shares issued	$ 45,000									$ 30,000
Conversion of debt, shares issued | shares	516,648									329,670
Conversion of debt, price per share | $ / shares	$ 0.09						$ 0.09
Tangiers Global, LLC [Member] | Securities Purchase Agreement [Member]
Debt And Convertible Loan Payable [Line Items]
Conversion of debt, shares issued | shares	516,648										3,280,255
Conversion of debt, price per share | $ / shares				$ 0.30
Proceeds from notes payable				$ 550,000
Original issue discount percentage			10.00%	10.00%
Conversion rate			65.00%
Number of trading days for conversion | Investors			15
Outstanding balance											$ 519,000
Guaranteed interest											$ 44,000
Debt face amount			$ 250,000
Original debt converted	$ 45,000
Percentage multiplied by principal and accrued interest			150.00%
Tangiers Global, LLC [Member] | Investment Agreement [Member]
Debt And Convertible Loan Payable [Line Items]
Conversion of debt, price per share | $ / shares		$ 0.1666
Conversion rate		200.00%
Number of trading days for conversion | Investors		8
Number of shares issued | shares		2,000,000
Maximum put amount		$ 250,000
Minimum put amount		$ 5,000
Debt discount percentage description		The purchase price per share to be paid by Tangiers will be the 80% of the of the average of the two lowest closing bid prices of the common stock during the pricing period applicable to the put notice, provided, however, an additional 10% will be added to the discount of each put if (i) we are not DWAC eligible and (ii) an additional 15% will be added to the discount of each put if we are under DTC "chill" status on the applicable date of the put notice
Debt face amount		$ 50,000
Debt maturity date		May 12, 2018
Tangiers Global, LLC [Member] | Investment Agreement [Member] | Fixed Convertible Promissory Note Due May 12, 2018 [Member]
Debt And Convertible Loan Payable [Line Items]
Conversion of debt, shares issued | shares											300,120
Conversion of debt, price per share | $ / shares		$ 0.1666
Conversion rate		65.00%
Number of trading days for conversion | Investors		10
Debt face amount		$ 50,000
Debt maturity date		May 12, 2018

Debt and Convertible Loan Pay_4

Debt and Convertible Loan Payable - Schedule of Debt Discount and Original Issuance Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt discount, beginning of period	$ 152,617
Additional debt discount and debt issue cost	383,786	417,834
Amortization of debt discount and debt issue cost	(466,862)	(265,217)
Debt discount, end of period	$ 69,541	$ 152,617

Debt and Convertible Loan Pay_5

Debt and Convertible Loan Payable - Schedule of Debt Issue Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt discount, beginning of period
Additional debt discount		20,000
Amortization of debt discount		(20,000)
Debt discount, end of period

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative expense	$ 0

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Change in Fair Value of the Derivative Liabilities (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Derivatives, Fair Value [Line Items]
Add fair value at the commitment date for convertible notes issued during the current year	$ 75,000
Less : current portion	341,464
Derivative Financial Instruments, Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liabilities - Beginning
Add fair value at the commitment date for convertible notes issued during the current year	213,453	270,331
Less derivatives due to conversion	(101,493)	(412,086)
Fair value mark to market adjustment for derivatives	442,957	141,755
Derivative liabilities - Ending	554,916
Less : current portion	(554,917)
Long-term derivative liabilities

Derivative Liabilities - Sche_2

Derivative Liabilities - Schedule of Derivative Liabilities Based Upon Management Assumptions (Details) - Derivative Financial Instruments, Liabilities [Member]	12 Months Ended
	Dec. 31, 2017
Commitment Date [Member] | Expected Dividend [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	0.00%
Commitment Date [Member] | Expected Volatility [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	134.00%
Commitment Date [Member] | Expected Term [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, expected term	5 months 1 day
Commitment Date [Member] | Risk Free Interest Rate [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	1.19%
Remeasurement Date [Member] | Expected Dividend [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	0.00%
Remeasurement Date [Member] | Expected Volatility [Member] | Minimum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	130.00%
Remeasurement Date [Member] | Expected Volatility [Member] | Maximum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	169.00%
Remeasurement Date [Member] | Expected Term [Member] | Minimum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, expected term	1 month 24 days
Remeasurement Date [Member] | Expected Term [Member] | Maximum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, expected term	4 months 9 days
Remeasurement Date [Member] | Risk Free Interest Rate [Member] | Minimum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	1.25%
Remeasurement Date [Member] | Risk Free Interest Rate [Member] | Maximum [Member]
Derivatives, Fair Value [Line Items]
Fair value measurement, interest rate	1.39%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Sep. 15, 2017	Sep. 06, 2017	Aug. 08, 2017	Jan. 16, 2017	May 09, 2016	Apr. 08, 2016	Mar. 01, 2015	Dec. 31, 2017	Dec. 31, 2016	Mar. 15, 2017
Related Party Transaction [Line Items]
Shares of common stock with a fair value								$ 566,930	$ 465,424
Shares issued price per share										$ 0.40
Common Stock [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares								1,549,840	1,327,380
Shares of common stock with a fair value								$ 1,550	$ 1,327
Issuance of common stock related to the merger, shares								7,584,008
Alamo Cbd LLC [Member]
Related Party Transaction [Line Items]
Shares issued price per share		$ 0.19
Alamo Cbd LLC [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares issued price per share		$ 0.19
Pawel Hardej [Member] | Director Agreement [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares					166,560
Shares of common stock with a fair value									$ 13,512
Shares issued price per share									$ 0.65
Issuance of common stock related to the merger, shares									20,820
Term period of services					2 years
John Zimmerman [Member] | Employment Agreement [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares						100,000
Shares of common stock with a fair value						$ 54,500
Shares issued price per share						$ 0.545
Percentage of purchase orders						5.00%
Percentage of facilities portion of purchase order						5.00%
Compensation payments schedule percentage rate, down payment						5.00%
Compensation payments schedule percentage rate, purchase order						50.00%
Compensation payments schedule percentage rate shipping						45.00%
Mr. Sykes [Member] | Founder and Chief of Cultivation [Member]
Related Party Transaction [Line Items]
Common stock returned by chief cultivation officer in anticipation of merger, shares			2,500,000
Director [Member] | Alamo Cbd LLC [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares of common stock with a fair value		$ 561,975
Shares issued price per share		$ 0.19
Issuance of common stock related to the merger, shares		2,957,763
Interim-Chief Executive Office, Chief Financial Officer And Director [Member] | Alamo Cbd LLC [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares of common stock with a fair value		$ 144,096
Issuance of common stock related to the merger, shares		758,401
William Jamieson [Member] | Director Agreement [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares					83,280
Shares of common stock with a fair value					$ 54,049
Shares issued price per share					$ 0.649
William Jamieson [Member] | Director Agreement [Member] | 2015 Stock Incentive [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares							166,560		83,280
Shares of common stock with a fair value									$ 36,435
Term period of services							2 years
William Jamieson [Member] | Director Agreement [Member] | 2015 Stock Incentive [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Shares issued price per share									$ 0.30
William Jamieson [Member] | Director Agreement [Member] | 2015 Stock Incentive [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Shares issued price per share									$ 0.5
Director Agreement [Member] | Pawel Hardej [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares				145,740
Shares of common stock with a fair value				$ 64,126
Shares issued price per share				$ 0.44
Director Agreement [Member] | John Zimmerman [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares				41,640
Shares of common stock with a fair value				$ 18,322
Shares issued price per share				$ 0.44
Director Agreement [Member] | John Choo [Member]
Related Party Transaction [Line Items]
Issuance of common stock for services, shares				62,460
Shares of common stock with a fair value				$ 27,482
Shares issued price per share				$ 0.44
Employment Agreement [Member] | Chief Financial Officer and Director and Former Chief Accounting Officer [Member] | Common Stock [Member]
Related Party Transaction [Line Items]
Shares of common stock with a fair value	$ 50,000
Shares issued price per share	$ 0.20
Issuance of common stock related to the merger, shares	250,000

Shareholders' Equity (Details N

Shareholders' Equity (Details Narrative)

Dec. 18, 2017USD ($)$ / sharesshares

Oct. 12, 2017USD ($)Investors$ / sharesshares

Oct. 10, 2017USD ($)Investors

Sep. 06, 2017USD ($)$ / sharesshares

Jun. 01, 2017USD ($)$ / sharesshares

May 03, 2017USD ($)Investors$ / sharesshares

Mar. 24, 2017USD ($)$ / shares

Mar. 20, 2017USD ($)$ / sharesshares

Jan. 17, 2017USD ($)$ / sharesshares

Sep. 26, 2016USD ($)$ / sharesshares

Aug. 29, 2016USD ($)Investorsshares

Aug. 29, 2016USD ($)

Mar. 31, 2016USD ($)$ / sharesshares

Mar. 23, 2016USD ($)$ / sharesshares

Mar. 22, 2016USD ($)Investors$ / sharesshares

Mar. 14, 2016USD ($)$ / sharesshares

Jan. 22, 2016USD ($)$ / sharesshares

Jan. 19, 2016USD ($)$ / sharesshares

Mar. 20, 2017USD ($)$ / shares

Mar. 15, 2017USD ($)Investors$ / sharesshares

Sep. 30, 2016USD ($)$ / sharesshares

Oct. 17, 2018USD ($)shares

Dec. 31, 2017USD ($)shares

Dec. 31, 2016USD ($)shares

Oct. 17, 2017$ / shares

Jun. 05, 2015USD ($)

Class of Stock [Line Items]

Number of investors | Investors

17

Amortization of debt discount

$ 515,814

$ 438,032

Number of shares issued | shares

2,060,000

824,000

Value of common shares issued

$ 824,000

$ 824,000

50,000

Value of common stock issued for services

566,930

465,424

Shares issued price per share | $ / shares

$ 0.40

Repayments of note payable

6,787

Debt face amount

$ 36,100

Interest rate

10.25%

Conversion of debt, fair value of shares issued

$ 75,000

Emerging Growth, Llc [Member]

Class of Stock [Line Items]

Issuance of common stock for services, shares | shares

125,000

Value of common stock issued for services

$ 43,750

Shares issued price per share | $ / shares

$ 0.35

Lyons Capital, LLC [Member]

Class of Stock [Line Items]

Issuance of common stock for services, shares | shares

800,000

Value of common stock issued for services

$ 352,000

Shares issued price per share | $ / shares

$ 0.44

Tangiers Global, LLC [Member]

Class of Stock [Line Items]

Conversion price per share | $ / shares

$ 0.09

$ 0.09

Conversion of debt, shares issued | shares

516,648

329,670

Conversion of debt, fair value of shares issued

$ 45,000

$ 30,000

Alamo Cbd LLC [Member]

Class of Stock [Line Items]

Number of shares issued | shares

758,401

Value of common shares issued

$ 144,096

Shares issued price per share | $ / shares

$ 0.19

Chuck Rifici Holdings Inc [Member]

Class of Stock [Line Items]

Repayments of note payable

$ 269,498

Original issue discount percentage

10.00%

Debt face amount

$ 225,500

Payment of purchase price

$ 204,000

Number of warrants to purchase common stock | shares

250,000

Warrant expiration term

1 year

Exercise price of warrant | $ / shares

$ 0.30

Warrant exercisable term

Sep. 26, 2017

Two Million Dollar Equity Financing Agreement [Member] | Kodiak Capital Group, LLC [Member]

Class of Stock [Line Items]

Number of shares issued | shares

300,000

Value of common shares issued

$ 120,000

Shares issued price per share | $ / shares

$ 0.40

Percentage of market price

80.00%

Securities Purchase Agreement [Member] | Firstfire Global Opportunities Fund, LLC, And Rockwell Capital Partners Inc [Member]

Class of Stock [Line Items]

Conversion price per share | $ / shares

$ 0.30

Number of shares issued | shares

50,000

Value of common shares issued

$ 23,500

Shares issued price per share | $ / shares

$ 0.47

Proceeds from notes payable

$ 272,500

Repayments of note payable

$ 250,000

Original issue discount percentage

9.00%

Debt maturity date

Sep. 22, 2016

Interest rate percentage on unpaid principal amount

3.00%

Debt default percentage

15.00%

Conversion rate

45.00%

Number of trading days for conversion | Investors

10

Securities Purchase Agreement [Member] | Firstfire Global Opportunities Fund, LLC [Member]

Class of Stock [Line Items]

Conversion price per share | $ / shares

$ 0.30

$ 0.30

Repayments of note payable

$ 252,917

Conversion of debt, shares issued | shares

333,333

Conversion of debt, fair value of shares issued

$ 100,000

Securities Purchase Agreement [Member] | Tangiers Global, LLC [Member]

Class of Stock [Line Items]

Conversion price per share | $ / shares

$ 0.30

Proceeds from notes payable

$ 550,000

Original issue discount percentage

10.00%

10.00%

Conversion rate

65.00%

Number of trading days for conversion | Investors

15

Conversion of debt, shares issued | shares

516,648

3,280,255

Proceeds from related party

$ 250,000

Debt face amount

250,000

Securities Purchase Agreement [Member] | Tangiers Global, LLC [Member] | Amendment #1 [Member]

Class of Stock [Line Items]

Proceeds from related party

$ 250,000

Consulting Agreement [Member]

Class of Stock [Line Items]

Issuance of common stock for services, shares | shares

250,000

Value of common stock issued for services

$ 55,000

Shares issued price per share | $ / shares

$ 0.22

Investment Agreement [Member] | Tangiers Global, LLC [Member]

Class of Stock [Line Items]

Conversion price per share | $ / shares

$ 0.1666

Number of shares issued | shares

2,000,000

Debt maturity date

May 12, 2018

Conversion rate

200.00%

Number of trading days for conversion | Investors

8

Debt face amount

$ 50,000

Interest rate

10.00%

Series A Convertible Preferred Stock [Member]

Class of Stock [Line Items]

Proceeds from issuance or sale of equity

$ 300,000

Number of investors | Investors

13

Conversion of stock, shares converted | shares

250,000

Conversion price per share | $ / shares

$ 0.30

$ 0.30

Number of stock sold during period | shares

750,000

Sale of stock, price per share | $ / shares

$ 0.40

Number of shares issued | shares

Value of common shares issued

Issuance of common stock for services, shares | shares

Value of common stock issued for services

Warrant [Member]

Class of Stock [Line Items]

Number of warrants issued | shares

250,000

Amortization of debt discount

$ 33,238

$ 0

$ 0

Common Stock [Member]

Class of Stock [Line Items]

Conversion of stock, shares converted | shares

416,667

Number of shares issued | shares

2,060,000

100,000

Value of common shares issued

$ 2,060

$ 100

Issuance of common stock for services, shares | shares

1,549,840

1,327,380

Value of common stock issued for services

$ 1,550

$ 1,327

Common Stock [Member] | Alamo Cbd LLC [Member]

Class of Stock [Line Items]

Shares issued price per share | $ / shares

$ 0.19

Investor [Member]

Class of Stock [Line Items]

Maximum number of equity units issued | shares

1,000,000

Description of equity units

Each Unit consists of one (1) share of Series A Convertible Preferred Stock and one (1) Series A Warrant ("Warrant").

Par value of equity units | $ / shares

$ 0.50

Proceeds from issuance or sale of equity

$ 125,000

$ 500,000

Number of investors | Investors

3

Consultant [Member]

Class of Stock [Line Items]

Issuance of common stock for services, shares | shares

5,000

11,330

Value of common stock issued for services

$ 2,050

$ 4,986

Shares issued price per share | $ / shares

$ 0.41

$ 0.44

US Accredited Investor [Member]

Class of Stock [Line Items]

Number of shares issued | shares

100,000

Value of common shares issued

$ 50,000

Shares issued price per share | $ / shares

$ 0.50

13 US Accredited Investor [Member] | Series A Convertible Preferred Stock 0.01 Par Value [Member]

Class of Stock [Line Items]

Number of investors | Investors

13

Number of shares issued | shares

750,000

Value of common shares issued

$ 300,000

Shares issued price per share | $ / shares

$ 0.40

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2017$ / sharesshares
Number of Warrants, Balance at beginning | shares	500,000
Number of Warrants, Granted | shares
Number of Warrants, Exercised | shares
Number of Warrants, Canceled/Forfeited | shares	250,000
Number of Warrants, Expired | shares	250,000
Number of Warrants, Balance at ending | shares
Weighted Average Exercise Price, Balance at beginning | $ / shares	$ 0.40
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Canceled/Forfeited | $ / shares	0.50
Weighted Average Exercise Price, Expired | $ / shares	0.30
Weighted Average Exercise Price, Balance at ending | $ / shares
Weighted Average Remaining Contractual Life (in Years) beginning	0 years
Weighted Average Remaining Contractual Life (in Years) end	0 years

Shareholders' Equity - Schedu_2

Shareholders' Equity - Schedule of Outstanding Warrants (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Class of Warrant or Right [Line Items]
Exercise Price Warrants Outstanding, Lower Range Limit	$ 0.30
Exercise Price Warrants Outstanding, Upper Range Limit	$ 0.50
Warrants Exercisable | shares	500,000
Weighted Average Remaining Contractual Life	8 months 9 days
Aggregate Intrinsic Value | $	$ 32,500

Shareholders' Equity - Schedu_3

Shareholders' Equity - Schedule of Common Stock Equivalents (Details) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents	3,580,375	2,550,654
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents	3,580,375	916,667
Convertible Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents		1,633,987

Shareholders' Equity - Schedu_4

Shareholders' Equity - Schedule of Common Stock Equivalents (Details) (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Convertible Debt Securities [Member]
Exercise price	$ 0.30	$ 0.30
Convertible Series A Preferred Stock [Member]
Exercise price	$ 0.08	$ 0.08

Income Taxes (Details Narrative

Income Taxes (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)
Income Tax Disclosure [Abstract]
Net operating loss carry forward	$ 5,856,768
Operating loss carry forward expiration term	Expire in 2037
Change in valuation allowance	$ 151,370
Change in valuation allowance attributable to tax rates	$ 8,000

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Net operating losses	$ 1,118,472	$ 1,005,468
Accelerated tax depreciation	19,183	19,183
Net deferred tax assets	1,137,655	986,285
Less: Valuation allowance	(1,137,655)	(986,285)
Net

Income Taxes - Schedule of Oper

Income Taxes - Schedule of Operating Loss Carry Forward (Details)	Dec. 31, 2017USD ($)
Operating Loss Carryforwards [Line Items]
Total	$ 5,856,768
Tax Year 2033 [Member]
Operating Loss Carryforwards [Line Items]
Total	217,074
Tax Year 2034 [Member]
Operating Loss Carryforwards [Line Items]
Total	368,378
Tax Year 2035 [Member]
Operating Loss Carryforwards [Line Items]
Total	761,615
Tax Year 2036 [Member]
Operating Loss Carryforwards [Line Items]
Total	1,610,192
Tax Year 2037 [Member]
Operating Loss Carryforwards [Line Items]
Total	$ 2,899,509

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Apr. 17, 2018USD ($)shares	Apr. 13, 2018USD ($)$ / sharesshares	Mar. 21, 2018USD ($)$ / sharesshares	Mar. 05, 2018USD ($)$ / sharesshares	Feb. 20, 2018USD ($)shares	Feb. 05, 2018shares	Jan. 16, 2018USD ($)Investors$ / shares	Jan. 15, 2018USD ($)shares	Jan. 09, 2018USD ($)$ / sharesshares	Mar. 24, 2017Investors$ / shares	Oct. 17, 2017USD ($)shares
Tangiers Note [Member]
Number of shares issued upon debt conversion | shares											329,670
Original debt converted											$ 30,000
Conversion of debt, price per share | $ / shares										$ 0.30
Conversion rate										65.00%
Number of trading days for conversion | Investors										15
Subsequent Event [Member] | Dr. Coleman and Benjamin Coleman [Member]
Number of shares returned and canceled | shares						3,280,470
Subsequent Event [Member] | Fowler Employment Agreement [Member] | Ms. Sandra Fowler [Member]
Initial term agreement expiration date								Jan. 15, 2019
Annual base salary								$ 48,000
Issuance of common stock for services shares | shares								200,000
Annual base salary after achieving certain milestone								$ 65,000
Subsequent Event [Member] | Fowler Employment Agreement [Member] | Ms. Sandra Fowler [Member] | Equity Securities [Member]
Sales of equity securities								$ 1,000,000
Subsequent Event [Member] | Weadock Employment Agreement [Member] | Mr. Daniel Weadock [Member]
Annual base salary					$ 100,000
Issuance of common stock for services shares | shares					300,000
Capitalization received					$ 2,000,000
Number of additional restricted common stock | shares					1,584,202
Subsequent Event [Member] | Director Agreement [Member] | Mr. Daniel Weadock [Member]
Issuance of common stock for services shares | shares					240,000
Subsequent Event [Member] | Tangiers Note [Member]
Number of shares issued upon debt conversion | shares	650,000								899,685
Original debt converted									$ 100,000
Conversion of debt, price per share | $ / shares							$ 0.30		$ 0.11
Initial term agreement expiration date	Jul. 16, 2018
Conversion rate							8.00%
Proceeds from notes payable							$ 550,000
Original issue discount percentage							10.00%
Outstanding balance	$ 231,660
Guaranteed interest	$ 17,160
Subsequent Event [Member] | Tangiers Note [Member] | 8% Fixed Convertible Promissory Note [Member]
Number of shares issued upon debt conversion | shares				269,716
Original debt converted				$ 25,000
Subsequent Event [Member] | Tangiers Note [Member] | 8% Fixed Convertible Promissory Note [Member]
Number of shares issued upon debt conversion | shares		769,231	295,631
Original debt converted		$ 50,000	$ 25,000
Conversion of debt, price per share | $ / shares		$ 0.07	$ 0.08	$ 0.09
Subsequent Event [Member] | Tangiers Note [Member] | Maturity Default [Member]
Conversion of debt, price per share | $ / shares							$ 0.30
Trading price percentage							65.00%
Number of trading days for conversion | Investors							15